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2	
Summary		
	
	
As	the	first	 line	of	defence	against	pathogens,	cells	mount	an	 innate	 immune	
response,	which	is	highly	variable	from	cell	to	cell.	The	response	must	be	potent	
yet	 carefully	 controlled	 to	 avoid	 self-damage.	 How	 these	 constraints	 have	
shaped	the	evolution	of	innate	immunity	remains	poorly	understood.	Here,	we	
characterise	this	programme’s	transcriptional	divergence	between	species	and	
expression	variability	across	cells.	Using	bulk	and	single-cell	transcriptomics	in	
primate	and	rodent	fibroblasts	challenged	with	an	immune	stimulus,	we	reveal	
a	striking	architecture	of	the	innate	immune	response.	Rapidly	diverging	genes,	
including	 cytokines	 and	 chemokines,	 also	 vary	 across	 cells	 and	 have	 distinct	
promoter	structures.	Conversely,	genes	involved	in	response	regulation,	such	as	
transcription	 factors	and	kinases,	are	conserved	between	species	and	display	
low	 cell-to-cell	 variability.	 We	 suggest	 that	 this	 unique	 expression	 pattern,	
observed	across	species	and	conditions,	has	evolved	as	a	mechanism	for	fine-
tuned	regulation,	to	achieve	an	effective	but	balanced	response.	
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3	
Introduction	
	
	
The	innate	immune	response	is	a	cell-intrinsic	defence	program	that	is	rapidly	
upregulated	 upon	 infection.	 It	 acts	 to	 inhibit	 pathogen	 replication	 while	5 
signalling	 the	 pathogen’s	 presence	 to	 other	 cells.	 This	 programme	 involves	
modulation	of	several	cellular	pathways,	 including	production	of	antiviral	and	
inflammatory	cytokines,	changes	in	translation	and	metabolism,	upregulation	of	
numerous	genes	functioning	in	cell	defence	and	pathogen	restriction,	and	the	
induction	of	regulated	cell	death1,2.	10 
	 An	important	characteristic	of	the	innate	immune	response	is	the	rapid	
evolution	that	many	of	its	genes	have	undergone	along	the	vertebrate	lineage.	
Comparative	 analyses	 across	 genomes	 have	 highlighted	 immune	 genes	 as	
having	extremely	rapid	coding	sequence	divergence3,4.	This	is	often	attributed	
to	pathogen-driven	selective	pressure5-8.	15 
	 Another	 hallmark	 of	 the	 innate	 immune	 response	 is	 its	 high	 level	 of	
heterogeneity	 among	 responding	 cells:	 various	 studies	have	 shown	 that	 cells	
display	extensive	cell-to-cell	variability	in	response	to	pathogen	infection9,10	and	
exposure	 to	 pathogen-associated	 molecular	 patterns	 (PAMPs)11,12.	 The	
functional	importance	of	this	cell-to-cell	variability	in	response	is	unclear.	20 
	 These	two	characteristics	–	rapid	divergence	 in	 the	course	of	evolution	
and	high	cell-to-cell	variability	–	seem	to	be	at	odds	with	the	strong	regulatory	
constraint	imposed	on	the	innate	immune	response:	the	need	to	execute	a	well-
coordinated	 and	 carefully	 balanced	 programme,	 to	 avoid	 long-term	 tissue	
damage	and	pathological	 immune	conditions13-16.	How	 this	 tight	 regulation	 is	25 
maintained	despite	rapid	evolutionary	divergence	and	high	cell-to-cell	variability	
remains	an	open	question,	central	to	our	understanding	of	the	innate	immune	
response	and	its	evolution.		
	 Here,	 we	 combine	 three	 genomics	 approaches	 to	 comprehensively	
characterize	the	transcriptional	changes	between	species	and	among	individual	30 
cells	 in	 their	 innate	 immune	 response	 (Fig	 1A).	 We	 use	 population	 (bulk)	
transcriptomics	to	investigate	transcriptional	divergence	between	species,	and	
single	cell	transcriptomics	to	estimate	cell-to-cell	variability	in	gene	expression.	
Through	 integration	 of	 these	 two	 approaches	 with	 chromatin	
immunoprecipitation	followed	by	sequencing	(ChIP-seq)	and	sequence	analyses,	35 
we	 study	 how	 changes	 in	 the	 expression	 of	 each	 gene	 between	 species	 and	
across	cells	relate	to	the	evolution	of	its	promoter	and	coding	sequence.	Finally,	
we	examine	the	relationship	between	divergence	in	sequence	and	expression	
and	 constraints	 imposed	 by	 host-pathogen	 interactions,	 to	 elucidate	 the	
evolutionary	architecture	of	the	innate	immune	response.	40 
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4	
	 Our	 experimental	 setup	 uses	 primary	 dermal	 fibroblasts,	 which	 are	
commonly	employed	in	immunological	and	virological	studies,	and	provide	an	
excellent	in	vitro	system	to	study	the	evolution	of	the	innate	immune	response	
across	species.	We	compare	the	response	of	dermal	fibroblasts	from	primates	
(human	 and	 rhesus	 macaque)	 and	 rodents	 (mouse	 and	 rat)	 to	 poly	 I:C,	 a	45 
synthetic	dsRNA.	Poly	 I:C,	a	primary	PAMP,	 is	 frequently	 	used	 to	mimic	viral	
infection	as	it	rapidly	elicits	an	innate	immune	response17.	
	 Using	this	model,	we	decipher	both	transcriptional	divergence	and	cell-
to-cell	variability,	allowing	us	to	probe	the	evolutionary	mechanisms	underlying	
the	heterogeneity	in	the	innate	immune	response.	50 
	
Results	
	
Estimating	transcriptional	divergence	in	the	dsRNA-response	across	species	 
	55 
To	 compare	 the	 transcriptional	 response	 across	 the	 four	 species	 (human,	
macaque,	 rat	and	mouse),	we	generated	bulk	RNA-sequencing	data	 from	the	
fibroblasts	of	each	species	after	stimulation	with	dsRNA	(poly	I:C)	for	4	hours,	
along	with	respective	controls	(see	Fig	1A,	Table	S1	and	Methods	for	detailed	
experimental	design	and	controls	used).	60 
	 In	 all	 species,	we	observe	 rapid	 upregulation	of	 expected	 antiviral	 and	
inflammatory	 genes,	 including	 IFNB,	 TNF,	 IL1A	 and	 CCL5,	 following	 dsRNA	
treatment	 (see	 also	 Table	 S2	 for	 upregulated	 pathways).	 Correlation	 analysis	
between	 species	 shows	 a	 similar	 transcriptional	 response	 (Fig	 S1A-C),	 as	
reported	in	other	immune	contexts18-20.	Furthermore,	the	response	tends	to	be	65 
more	 conserved	 between	 closely	 related	 species	 (Fig	 S1I),	 similarly	 to	 other	
expression	programmes21-25.		
	 We	characterized	the	differences	between	species	in	response	to	dsRNA	
for	each	gene,	using	this	cross-species	bulk	transcriptomics	data.	While	some	
genes,	 such	 as	 the	NF-!B	 subunits	 RELB	 and	NFKB2,	 have	 a	 similar	 response	70 
across	species	 (Fig	1B),	other	genes	respond	differently	between	the	primate	
and	the	rodent	clades.	For	example,	IFI27	(a	restriction	factor	against	numerous	
viruses)	is	strongly	upregulated	in	primates	but	not	in	rodents,	while	DAXX	(an	
important	 antiviral	 transcriptional	 repressor)	 exhibits	 the	 opposite	 behaviour	
(Fig	1B).	Conversely,	some	genes	have	species-specific	response	patterns.	For	75 
example,	 IL7RA	 (a	 cytokine	 receptor)	 is	 upregulated	 in	 response	 to	dsRNA	 in	
human,	 macaque	 and	 rat,	 but	 not	 in	 mouse,	 in	 agreement	 with	 previous	
observations	 from	 LPS	 stimulation	 of	 human	 and	mouse	macrophages19	 (see	
additional	examples	in	Figs	1B	and	S2).		
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5	
	 To	 quantify	 divergence	 in	 transcriptional	 response	 to	 dsRNA	 between	80 
species,	 we	 focused	 on	 genes	 that	 are	 differentially	 expressed	 in	 human	 in	
response	to	dsRNA	(see	Methods).	For	simplicity,	we	will	refer	to	these	genes	as	
“dsRNA-response	genes”	 (Fig	1C).	 There	are	955	 such	genes	with	one-to-one	
orthologs	across	the	species.			
For	each	gene,	we	fitted	models	that	 incorporate	selection	and	genetic	85 
drift	to	the	changes	in	gene	expression	after	stimulation	across	the	four	species	
(Ornstein–Uhlenbeck	model26	-	hereafter	OU	model,	see	Fig	1C	and	Methods	for	
additional	 details).	 This	 procedure	 provides	 a	 measure	 of	 divergence	 in	
transcriptional	response	to	dsRNA	between	species	that	is	comparable	across	all	
genes	(hereafter	“response	divergence”).		90 
For	subsequent	analyses,	we	split	the	955	dsRNA-response	genes,	based	
on	 their	 level	of	 response	divergence,	 into	 three	groups:	 (1)	highly	divergent	
dsRNA-response	genes	(the	top	25%	genes	with	the	highest	divergence	values	
in	 response	 to	 dsRNA	 across	 the	 four	 studied	 species),	 (2)	 lowly	 divergent	
dsRNA-response	 genes	 (the	 bottom	 25%),	 and	 (3)	 genes	 with	 medium	95 
divergence	across	species	(the	middle	50%)	(Fig	1C).	
	 We	 confirmed	 the	 results	 of	 the	 OU	 divergence	 model	 by	 observing	
agreement	 between	 these	 values	 and	 divergence	 measures	 obtained	 by	 a	
different	model	(linear	models	between	species	-	Fig	S3).	We	then	performed	
ChIP-seq	 of	 stimulated	 and	 unstimulated	 cells	 in	 all	 species	 to	 profile	 two	100 
histone	 marks:	 H3K4me3	 and	 H3K27ac.	 Both	 of	 these	 marks	 are	 present	 at	
active	 promoters,	while	H3K27ac	without	H3K4me3	 is	 associated	with	 active	
enhancers.	Our	analysis	showed	that	divergence	in	gene	expression	corresponds	
to	divergence	of	active	promoters	and	enhancers	across	 the	 four	species	 (Fig	
S4).		105 
	 	
Rapidly	diverging	genes	have	a	distinct	promoter	architecture		
	
Next,	we	tested	whether	divergence	in	transcriptional	response	is	reflected	in	
promoter	sequence	conservation	and	architecture.	For	this,	we	compared	the	110 
conservation	of	the	500	bases	upstream	of	the	transcription	start	site	(TSS)	in	
highly	divergent	dsRNA-response	genes	with	conservation	of	the	corresponding	
region	in	medium	and	lowly	divergent	genes	(Fig	2A).	
	 Interestingly,	genes	that	highly	diverge	in	response	show	higher	sequence	
conservation	 in	 this	 region.	 Thus,	 despite	 having	 a	 relatively	 conserved	115 
promoter	sequence,	these	genes	dramatically	differ	in	their	expression	levels	in	
response	to	dsRNA	between	species.	This	surprising	discordance	may	be	related	
to	the	fact	that	promoters	of	highly	and	lowly	divergent	genes	have	different	
architectures,	 which	 impose	 different	 constraints	 on	 promoter	 sequence	
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6	
evolution19,27,28.	Promoters	containing	TATA-box	elements	tend	to	have	most	of	120 
their	 regulatory	elements	 in	 regions	 immediately	upstream	of	 the	TSS.	These	
promoters	are	thus	expected	to	be	more	conserved.	The	opposite	is	true	for	CpG	
island	 (CGI)	 promoters27.	 Indeed,	 we	 found	 that	 TATA-box	 elements	 tend	 to	
occur	 in	 promoters	 of	 highly	 divergent	 genes,	 while	 CGIs	 occur	 in	 more	
conserved	genes	 (Fig	2B).	Thus,	a	promoter	architecture	enriched	with	TATA-125 
boxes	and	depleted	of	CGIs	is	associated	with	higher	transcriptional	divergence,	
while	 entailing	 higher	 sequence	 conservation	 upstream	 of	 these	 genes.	
Conversely,	 genes	 with	 CGI	 promoters	 tend	 to	 be	 transcriptionally	
conserved19,27,28.		
	130 
Cytokines	and	chemokines	diverge	more	rapidly	than	other	responding	genes	
		
	 We	next	asked	whether	dsRNA-response	genes	from	different	functional	
classes	diverge	in	their	transcriptional	response	at	different	evolutionary	rates.	
For	 this,	we	divided	 the	955	dsRNA-response	genes	 into	different	 categories,	135 
based	on	their	 function	(such	as	cytokines,	transcriptional	 factors,	kinases)	or	
based	 on	 the	 processes	 in	 which	 they	 are	 known	 to	 be	 involved	 (such	 as	
apoptosis	or	inflammation).	We	observed	that	genes	that	are	related	to	cellular	
defence	 and	 inflammation	 –	 most	 notably	 cytokines,	 chemokines	 and	 their	
receptors	–	tend	to	diverge	in	response	significantly	faster	than	genes	involved	140 
in	apoptosis	or	immune	regulation	(chromatin	modulators,	transcription	factors,	
kinases	 and	 ligases)	 (Fig	 2C-D).	 Similar	 findings	 regarding	divergence	 rates	 of	
different	 functions	 of	 responding	 genes	were	 observed	 in	 response	 to	 direct	
IFNB	 treatment,	 which	 we	 used	 as	 an	 additional	 immune	 challenge	 for	
comparison	(Fig	S5).		145 
In	summary,	we	have	 identified	a	group	of	genes	 that	have	undergone	
relatively	 fast	divergence	 in	 their	 transcriptional	 response	 to	dsRNA	between	
the	 four	 studied	 species.	 These	 genes	 have	 a	 distinct	 promoter	 architecture.	
Furthermore,	these	genes	have	specific	functions	in	innate	immunity	related	to	
cellular	defence	and	 inflammation,	 including	cytokines,	chemokines	and	 their	150 
receptors.	 In	 contrast,	 dsRNA-induced	 genes	 involved	 immune	 response	
regulation	 (such	 as	 kinases	 and	 transcription	 factors)	 are	more	 conserved	 in	
their	transcriptional	response.	
	
Rapidly	diverging	genes	have	high	cell-to-cell	variability	in	expression	155 
	
Previous	 studies	 have	 shown	 that	 the	 innate	 immune	 response	displays	 high	
variability	across	responding	cells29,30.	However,	the	relationship	between	cell-
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7	
to-cell	 transcriptional	 variability	 and	 response	 divergence	 between	 species	 is	
not	well-understood.	160 
	 To	study	gene	expression	heterogeneity	across	cells,	we	used	single-cell	
RNA-seq	to	profile	the	transcriptomes	of	hundreds	of	 individual	cells	 from	all	
species	 in	 a	 time	 course	 of	 0,2,4	 and	 8	 hours	 after	 dsRNA	 stimulation.	 We	
estimated	cell-to-cell	variability	quantitatively	using	an	established	measure	for	
variability:	“distance	to	median”	(DM,	see	Methods)31.	This	measure	has	been	165 
previously	 used	 to	 infer	 variability	 from	 single-cell	 RNA-seq	 data32,33,	 and	
accounts	for	the	confounding	factor	of	gene	expression	level	(Fig	S6).		
	 We	determined	the	relationship	between	divergence	across	species	and	
cell-to	cell	variability	for	the	955	dsRNA-response	genes	(Fig	3A).	Strikingly,	we	
found	a	clear	trend	where	genes	that	are	highly	divergent	in	response	between	170 
species	 are	 also	 more	 variable	 in	 expression	 across	 individual	 cells	 within	 a	
species.	 The	 relationship	 between	 rapid	 divergence	 and	 high	 cell-to-cell	
variability	holds	in	each	species	and	each	stimulation	time	point	(Fig	S7).	
		 We	 confirmed	 that	 these	 results	 are	 not	 biased	 by	 particular	
computational	or	experimental	settings	(Figs	S8-9):	(1)	by	repeating	the	analyses	175 
with	 a	 second	 computational	 approach	 -	 	 BASiCS	 	 (a	 novel	 approach	 to	 infer	
variability	 that	 discerns	 biological	 variability	 from	 technical	 noise	 by	 utilizing	
observed	 levels	of	 synthetic	 spiked-in	RNA	molecules34),	 (2)	 by	 repeating	 the	
analysis	with	a	second	biological	replicate	from	each	species,	and	(3)	by	profiling	
thousands	of	human	cells	that	were	processed	using	a	different	experimental	180 
technique	 (Fig	 S8).	 Furthermore,	 we	 confirmed	 that	 cell-to-cell	 variability	 in	
response	does	not	stem	from	different	overall	levels	of	response	(Fig	S10).			
	 Thus,	 the	 set	 of	 genes	 rapidly	 diverging	 in	 response	 to	 dsRNA	 across	
species	also	displays	high	cell-to-cell	variability	in	expression	within	a	species	-	a	
relationship	that	is	consistent	across	all	species	and	stimulation	time	points.	185 
	
High	cell-to-cell	variability	 in	expression	is	associated	with	unique	promoter	
architecture		
	
Next,	 we	 examined	 the	 relationship	 between	 the	 presence	 of	 promoter	190 
elements	 –	 CpG	 islands	 (CGIs)	 and	 TATA-boxes	 -	 and	 a	 gene’s	 cell-to-cell	
variability.	We	observed	that	genes	that	are	predicted	to	have	a	TATA-box	 in	
their	 promoter	 have	 significantly	 higher	 transcriptional	 variability,	while	 CGI-
genes	 tend	 to	 have	 significantly	 lower	 variability	 (Fig	 3B).	 Thus,	 both	
transcriptional	variability	between	cells	(Fig	3B)	and	transcriptional	divergence	195 
between	species	(Fig	2B)	are	associated	with	the	presence	of	specific	promoter	
elements.	TATA-box	presence	is	associated	with	high	divergence	and	variability,	
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8	
while	CGIs	occur	in	promoters	of	genes	with	conserved	transcriptional	response	
and	low	cell-to-cell	variability.			
	200 
Cytokines	and	chemokines	display	high	levels	of	cell-to-cell	variability	across	
species	and	conditions		
	
We	subsequently	investigated	the	transcriptional	cell-to-cell	variability	of	three	
groups	 of	 dsRNA-response	 genes	 with	 different	 functions:	 cytokines	 and	205 
chemokines	 (hereafter	 “cytokines”),	 transcription	 factors,	 and	 kinases	 and	
phosphatases	(hereafter	“kinases”).	Cytokines	rapidly	diverge	in	transcriptional	
response,	while	the	genes	in	the	other	two	groups	are	relatively	conserved	(Fig	
2C).	We	compared	response	divergence	across	species	with	levels	of	cell-to-cell	
variability	 for	 each	dsRNA-response	 gene	 (Fig	 3C).	 In	 contrast	 to	 kinases	 and	210 
transcription	factors,	many	cytokines	display	relatively	high	levels	of	cell-to-cell	
variability.	 This	 high	 variability	 is	 a	manifestation	 of	 cytokine	 expression	 in	 a	
small	subset	of	cells	(Fig	S11).		The	expression	of	cytokines	in	only	a	subset	of	
cells	within	a	responding	cell	population	has	been	reported	for	several	cytokines	
in	 various	 innate	 and	 adaptive	 immune	 scenarios30.	 For	 example,	 IFNB	 is	215 
expressed	 in	 only	 a	 small	 fraction	 of	 cells	 infected	 with	 different	 viruses	 or	
challenged	with	 various	 stimuli9,12,35.	 Here,	 we	 observed	 that	 cytokines	 from	
several	different	families	 (e.g.	 IFNB,	CXCL10,	CCL2)	are	upregulated	 in	a	small	
fraction	 of	 the	 stimulated	 cells,	 and	 thus	 exhibit	 high	 levels	 of	 expression	
heterogeneity	between	cells.		220 
	When	looking	at	the	progression	of	the	response	to	dsRNA	along	a	time	
course	of	2,	4	and	8hrs,	we	observe	that	the	cell-to-cell	variability	of	cytokines	
is	relatively	high	at	all	time	points,	in	comparison	with	kinases	and	transcription	
factors	 that	 display	 relatively	 low	 variability	 (Fig	 3D).	 This	 pattern	 is	 similar	
across	 all	 species	 (Fig	 S12).	 Thus,	 the	 high	 variability	 of	 cytokines	 and	 their	225 
expression	 in	 a	 small	 fraction	 of	 stimulated	 cells	 across	 all	 time	 points	 is	
evolutionarily	conserved	(Figs	S11-12).	
	
Co-expression	 of	 cytokines	 with	 upstream	 regulators	 is	 conserved	 across	
species		230 
	
When	analysing	cytokine	expression	across	dsRNA-stimulated	human	cells,	we	
found	a	group	of	13	cytokines	and	chemokines	that	tend	to	be	co-expressed	in	
the	same	cells	(Fig	S13A).	This	set	includes	some	of	the	most	heterogeneously	
expressed	cytokines,	such	as	IFNB1,	CXCL10,	CXCL11,	CCL2	and	CCL5	(Fig	S13B).	235 
This	raises	the	possibility	that	the	expression	of	these	cytokines	is	coordinated.	
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9	
	 To	 further	 investigate	 this,	 we	 calculated	 the	 correlations	 between	
expression	 of	 these	 13	 cytokines	 and	 other	 expressed	 genes	 across	 dsRNA-
stimulated	cells.	We	observed	that	the	set	of	genes	correlating	with	these	13	
cytokines	 (genes	with	 >0.3	 R-Spearman	 correlation)	 is	 enriched	 in	 GO	 terms	240 
related	to	the	innate	immune	response,	such	as	“Defence	response	to	virus”	and	
“Type	I	interferon	signalling	pathway”	(Table	S3A).			
	 Next,	we	repeated	the	same	correlation	analysis	in	macaque,	mouse	and	
rat	cells.	We	showed	that	the	set	of	orthologs	of	genes	identified	in	human	as	
correlating	 with	 cytokines	 is	 significantly	 co-expressed	 with	 cytokines	 in	 the	245 
other	 species	 (see	 Methods).	 Among	 the	 genes	 co-expressed	 with	 the	 13	
cytokines	in	human,	25	genes	show	conservation	of	a	high	correlation	with	the	
same	cytokines	across	all	four	species	(Table	S3B).	This	set	is	enriched	with	genes	
known	to	be	involved	in	cytokine	regulation.		
As	an	example,	we	 identified	the	genes	whose	expression	 is	correlated	250 
with	the	chemokine	CXCL10	in	at	least	two	species	(Figs	3E	and	S14).	This	set	of	
genes	includes	4	cytokines	that	are	co-expressed	with	CXCL10,	and	10	genes	that	
are	known	regulators	of	the	innate	immune	response	and	cytokine	production.	
Examples	of	these	genes	include	the	viral	sensors	and	dsRNA	binding	proteins	
MDA5	 and	 RIG-I,	 and	 their	 regulator	 and	 binding	 partner	 DHX58.	 This	 is	 in	255 
agreement	with	previous	findings	that	suggest	that	IFNB	expression	is	limited	to	
cells	 where	 important	 upstream	 regulators	 are	 expressed	 at	 high	 enough	
levels9,12,35.	 Here,	 we	 showed	 that	 this	 phenomenon	 of	 co-expression	 with	
upstream	regulators	applies	to	a	wider	set	of	cytokines	and	is	conserved	across	
species.	260 
In	summary,	we	observe	that	cytokines	are	expressed	in	a	small	subset	of	
cells,	 giving	 rise	 to	 high	 cell-to-cell	 variability	 in	 transcriptional	 response	 to	
dsRNA.	This	pattern	is	seen	across	species	and	different	stimulation	time	points,	
and	is	associated	with	expression	of	genes	known	to	be	upstream	regulators	of	
cytokine	production.	265 
	
Transcriptionally	divergent	genes	also	evolve	rapidly	in	protein	sequence		
	
Above,	we	characterised	genes	that	rapidly	diverge	in	response	to	dsRNA,	and	
showed	 that	 these	 genes	 are	 also	 variable	 in	 expression	 across	 cells.	 Many	270 
immune	 genes,	 including	 some	 cytokines	 and	 their	 receptors,	 are	 known	 to	
evolve	 rapidly	 in	 coding	 sequence	 compared	 to	 all	 other	 genes3,6.	 However,	
whether	divergence	in	transcriptional	response	in	immune	genes	is	related	to	
divergence	in	coding	sequence	is	not	known.		
	 This	 prompted	 us	 to	 examine	 the	 relationship	 between	 divergence	 in	275 
response	and	divergence	in	coding	sequence.	For	these	analyses,	we	used	the	
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10	
set	of	955	dsRNA-response	genes,	and	assessed	the	coding	sequence	evolution	
in	the	three	subsets	of	lowly,	medium	and	highly	divergent	genes	(as	defined	in	
Fig	1C).	
	 We	compared	the	rate	at	which	genes	evolved	in	their	coding	sequences	280 
with	 their	 response	 divergence	 by	 considering	 the	 ratio	 between	 non-
synonymous	 (dN)	 to	 synonymous	 substitutions	 (dS).	We	observed	 that	genes	
that	 rapidly	 evolve	 in	 transcriptional	 response	 have	 higher	 coding	 sequence	
divergence	 (higher	 dN/dS	 values)	 than	 dsRNA-response	 genes	 with	 low	
response	divergence	(Fig	4A).		285 
	
Transcriptionally	divergent	genes	have	higher	rates	of	gene	gain	and	loss	in	
the	course	of	mammalian	evolution	
	
Next,	we	tested	the	relationship	between	a	gene’s	divergence	in	response	and	290 
the	rate	at	which	the	gene’s	family	has	expanded	and	contracted	in	the	course	
of	 vertebrate	 evolution.	 Rapid	 gene	 duplication	 and	 gene	 loss	 have	 been	
observed	in	several	important	immune	genes36-41.	This	has	been	hypothesized	
to	be	a	result	of	pathogen-driven	pressure42,43.	
	 We	used	the	statistics	provided	in	ENSEMBL,	where	the	relative	rate	of	295 
gene	duplication	and	loss	across	vertebrates	is	assessed	using	a	model	based	on	
global	birth-and-death	rates44.	We	found	that	transcriptionally	divergent	dsRNA-
response	genes	have	undergone	faster	rates	of	gene	gain	and	loss	(Fig	4B).	
	 Higher	rates	of	gene	gain	and	loss	in	a	gene	family	imply	that	at	least	some	
genes	in	these	gene	families	are	evolutionarily	younger.	We	thus	investigated	300 
the	evolutionary	age	of	the	set	of	dsRNA-response	genes	using	eleven	different	
combinations	 of	 age	 estimation	 parsimonies	 and	 vertebrate	 gene	 families	
obtained	 from	ProteinHistorian45.	 Indeed,	 genes	 that	 diverge	more	 rapidly	 in	
their	 dsRNA-response	 are	 evolutionarily	 younger	 (Figs	 4C	 Fig	 S15A).	 It	 is	
important	 to	 note	 that	 gene	 age	 estimations	 are	 not	 confounded	 by	 coding	305 
sequence	 evolution	 (Fig	 S15B).	 Thus,	 the	 two	 evolutionary	 mechanisms	 we	
studied	-	gene	gain	and	loss	and	coding	sequence	evolution	-	are	independent.	
	 Previous	reports	suggest	that	younger	genes	tend	to	have	fewer	protein-
protein	 interactions	 within	 cells46.	We	 indeed	 observe	 that	 rapidly	 diverging	
genes	(in	both	expression	and	protein	sequence)	tend	to	have	fewer	protein-310 
protein	 interactions	 (obtained	 from	 STRING47).	 This	 agrees	 with	 the	 above	
finding	on	gene	age	(Fig	4D).	
		 Together,	 these	 results	 suggest	 that	 transcriptionally	 divergent	 dsRNA-
response	 genes	 evolve	 rapidly	 through	 various	 mechanisms,	 including	 fast	
coding	sequence	evolution	and	higher	rates	of	gene	loss	and	duplication	events.			315 
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Viruses	evolve	to	preferentially	interact	with	conserved	innate	immune	
genes		
	
	 Pathogens	are	a	major	selective	pressure	in	mammalian	evolution5,6,	and	320 
are	thought	to	drive	the	evolution	of	immune	genes.	We	thus	investigated	the	
relationship	 between	 transcriptional	 divergence	 and	 interactions	 with	 viral	
proteins	 by	 compiling	 a	 dataset	 of	 known	 host-virus	 interactions5,48,49.	
Interestingly,	 dsRNA-response	 genes	 with	 no	 known	 viral	 interactions	 have	
higher	 response	 divergence	 than	 genes	 with	 viral	 interactions	 (Fig	 4E).	325 
Furthermore,	 the	 subset	 of	 dsRNA-response	 genes	 that	 are	 targeted	 by	 viral	
immunomodulators50	-	viral	proteins	that	subvert	the	host	immune	system	-	is	
even	more	conserved	than	the	overall	set	of	genes	that	interact	with	any	viral	
protein	(Fig	4E).	This	suggests	that	viruses	have	evolved	to	interact	with	innate	
immune	proteins	 that	 are	 relatively	 conserved.	 Presumably,	 these	 conserved	330 
host	genes	cannot	evolve	away	from	these	viral	interactions51.	
	 	
Our	results	are	summarized	in	Fig	4F,	which	shows	how	representative	dsRNA-
response	genes	differ	in	both	the	evolutionary	and	regulatory	characteristics	we	
have	 studied.	Cytokines,	 chemokines	and	 their	 receptors	evolve	 rapidly	 in	all	335 
evolutionary	modes	and	have	higher	 transcriptional	 variability	across	cells.	 In	
contrast,	 dsRNA-induced	 genes	 that	 are	 involved	 in	 immune	 response	
regulation,	such	as	kinases	and	transcription	factors,	are	more	conserved	and	
less	heterogeneous	across	cells.	These	genes	have	higher	numbers	of	cellular	
protein-protein	 interactions,	 suggesting	 higher	 constraints	 imposed	 on	 their	340 
evolution.	 This	 latter	 group	 of	 conserved	 genes	 is	 more	 often	 targeted	 by	
viruses,	 revealing	 a	 relationship	 between	 host-pathogen	 dynamics	 and	 the	
evolutionary	architecture	of	the	innate	immune	response.			
	
Discussion	345 
	
In	this	work,	we	have	taken	an	integrative	approach	to	chart	the	evolutionary	
architecture	of	the	innate	immune	response.	In	particular,	we	have	focused	on	
the	 relationship	 between	 a	 gene’s	 cell-to-cell	 variability	 and	 its	 expression	
divergence	between	species.	To	dissect	this	relationship,	we	combined	bulk	and	350 
single-cell	RNA-sequencing	approaches	with	ChIP-sequencing	experiments	and	
molecular	evolutionary	analyses.	We	make	this	data	available	in	an	interactive	
web	resource	at:		https://teichlab.sanger.ac.uk/ImmunityEvolution.	
	 We	 find	 that	 rapidly	 diverging	 genes	 are	 also	 highly	 variable	 between	
cells.	 Both	 of	 these	 characteristics	 are	 associated	with	 a	 particular	 promoter	355 
architecture.	 Moreover,	 genes	 with	 rapid	 expression	 divergence	 also	 evolve	
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12	
more	rapidly	in	other	evolutionary	mechanisms:	they	are	more	divergent	at	the	
level	of	protein	sequence,	and	undergo	rapid	gene	gain	and	loss	events.	
	 Importantly,	 we	 find	 that	 genes	 involved	 in	 different	 functions	 in	 the	
innate	immune	response	diverge	at	different	rates.	Genes	related	to	response	360 
regulation	are	more	conserved,	while	cytokines	and	chemokines	diverge	rapidly.	
Many	 cytokines	 and	 chemokines	 have	 high	 cell-to-cell	 variability,	 and	 are	
expressed	in	relatively	few	cells.		
	 One	 of	 the	 central	 findings	 of	 our	 work	 is	 the	 observation	 that	 genes	
rapidly	 diverging	 between	 species	 exhibit	 higher	 levels	 of	 variability	 in	 their	365 
transcription	 across	 individual	 cells.	 Both	 characteristics	 -	 increased	
transcriptional	divergence	and	heterogeneity	across	cells	-	are	associated	with	a	
similar	promoter	architecture:	genes	whose	promoters	are	enriched	with	TATA-
boxes	 and	 depleted	 of	 CGIs,	 tend	 to	 be	 rapidly	 evolving	 and	 more	 variable	
between	cells.	This	agrees	with	previous	work	 in	yeast,	where	CGI	promoters	370 
were	linked	to	low	cell-to-cell	variability	and	conservation	in	expression.	TATA-
box	promoters	were	associated	with	genes	with	rapid	transcriptional	divergence	
between	 species	 and	 high	 variability	 in	 protein	 expression31,52.	 Interestingly,	
yeast	 genes	 with	 high	 transcriptional	 variability	 are	 often	 involved	 in	 stress	
responses	 and	 have	 a	 high	 dynamic	 range	 in	 their	 response31.	 This	 suggests	375 
intriguing	analogies	between	the	regulation	of	genes	involved	in	stress	response	
in	yeast,	and	the	regulation	of	the	mammalian	 innate	 immune	response,	two	
systems	 that	 may	 have	 been	 subjected	 to	 accelerated	 evolution	 due	 to	
continuous	changes	in	external	stimuli.				
Cytokines	 and	 chemokines	 display	 the	 highest	 transcriptional	 variability,	380 
being	 expressed	 in	 only	 a	 small	 subset	 of	 cells.	 This	 is	 observed	 across	 all	
stimulation	conditions	and	species	studied,	and	is	in	agreement	with	previous	
findings	 showing	 specific	 examples	 of	 cytokines	 expressed	 in	 a	 subset	 of	
responding	cells30.	We	observe	 that	cytokines	tend	to	be	co-expressed	 in	 the	
same	cells.	Moreover,	they	correlate	in	expression	with	genes	that	are	known	385 
to	 be	 upstream	 regulators	 of	 the	 innate	 immune	 response,	 and	 this	 co-
expression	is	conserved	across	species.	This	might	indicate	that	the	high	cell-to-
cell	variability	observed	in	cytokine	expression	is	functionally	important.	Since	
prolonged	 or	 increased	 cytokine	 expression	 can	 result	 in	 tissue	 damage53-55,	
restricting	 cytokine	 production	 to	 only	 a	 few	 cells	might	 assist	 in	 preventing	390 
pathological	 immune	conditions	such	as	autoimmunity.	Therefore,	expressing	
cytokines	in	just	a	few	cells	might	be	sufficient	to	activate	the	innate	immune	
response	in	nearby	cells	and	recruit	immune	cells,	while	retaining	the	ability	to	
switch	off	the	response	in	a	controlled	manner9.	
In	contrast	to	cytokines,	we	observe	that	genes	involved	in	regulation	of	the	395 
immune	response	–	such	as	transcription	factors	and	kinases	-	are	less	variable	
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13	
between	 cells,	 and	 are	 less	 diverging	 in	 transcriptional	 response	 along	 with	
other	 evolutionary	mechanisms.	 These	 genes	might	 have	 stronger	 functional	
and	regulatory	constraints,	due	to	their	roles	in	multiple	contexts	and	pathways	
unrelated	to	innate	immunity.	These	constraints	limit	their	ability	to	evolve;	an	400 
Achilles’	heel	 that	 can	be	used	by	pathogens	 to	 subvert	 the	 immune	system.	
Indeed,	we	 observe	 that	 viruses	 have	 evolved	 to	 preferentially	 interact	with	
conserved	 factors	 in	 the	 innate	 immune	 response,	 possibly	 exploiting	 the	
constraints	imposed	on	these	genes	that	limit	their	ability	to	evolve	away	from	
viral	interactions.	405 
Due	 to	 these	 constraints,	 we	 suggest	 that	 a	 successful	 host	 strategy	 is	
manifested	through	cytokines	and	other	secreted	immune	proteins.	Not	only	do	
they	 act	 as	 an	 efficient	means	 of	 alerting	 neighbouring	 and	 immune	 cells	 of	
pathogen	 presence,	 they	 also	 function	 as	 an	 important	 element	 in	 the	
evolutionary	arms	race.	This	stems	from	their	ability	to	readily	evolve	with	fewer	410 
constraints	 imposed	 by	 intracellular	 interactions	 or	 additional	 non-immune	
functions.	This	evolution	manifests	through	multiple	mechanisms:	divergence	in	
expression	 levels,	changes	 in	coding	sequences	and	gene	duplication	and	loss	
events.		
Our	 work	 thus	 reveals	 the	 underlying	 architecture	 of	 the	 innate	 immune	415 
response,	linking	promoter	structure	and	transcription	with	evolution,	function	
and	host-pathogen	 interactions.	Our	 results	 suggest	 that	 rapid	evolution	and	
high	 levels	 of	 expression	 heterogeneity	 are	 prominent	 in	 genes	with	 specific	
functions	 in	 the	 innate	 immune	 response.	 Those	 genes	 that	 are	 involved	 in	
regulation	tend	to	be	conserved,	whereas	cytokines	diverge	rapidly	and	exhibit	420 
high	 variability	 between	 cells.	 These	 characteristics	may	 enable	 cytokines	 to	
induce	 a	 rapid,	 yet	 controlled,	 response	 across	 the	 tissue	 and	 to	 avoid	 long-
lasting	and	potentially	damaging	effects.	
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Figure 1: Transcriptional divergence in the dsRNA response
(A) Study design: Primary dermal fibroblasts from four species - stimulated with dsRNA, or controls (unstimulated cells, mock
transfection), or an alternative stimulation (IFNB). Samples were collected for population (bulk) and single-cell RNA-seq and for ChIP-seq.
(B) Fold change in response to dsRNA in six example genes across the four species: NFKB2, RELB, IFI27, DAXX, IL7RA and SAMHD1.
(C) Estimating each gene’s level of cross-species divergence in transcriptional response: (1) Using edgeR, the fold change in expression
in response to dsRNA (in comparison to mock transfection) was assessed for each gene in each species. (2) Differentially expressed
genes were identified using the edgeR exact test (FDR-corrected q-value<0.01), out of which 955 have one-to-one orthologs across the
four studied species. (3) Ornstein-Uhlenbeck models were fitted to the fold change data for each gene, using the expression changes of
the four orthologs and the known phylogeny (see Methods). Genes were grouped into ‘low’, ‘medium’ and ‘high’ divergence for
subsequent analysis.
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Figure 2: Transcriptional response divergence, promoter architecture and gene function 
(A) Promoter sequence conservation and transcriptional response divergence: Sequence conservation values are estimated with phyloP7
(higher values indicate higher conservation) for 500bp upstream the transcription start site (TSS). Mean conservation values each bp in
this region upstream of the TSS are shown for highly-, medium- and lowly-divergent genes. Genes that are highly-divergent have higher
sequence conservation (p=3.8x10-7, two-sample Kolmogorov-Smirnov test).
(B) Comparison of divergence in response of genes with and without a TATA-box (left) and CpG Islands (CGIs) (right). Divergence in
response values (y-axis) are taken from the Ornstein-Uhlenbeck model. Empirical p-values are shown.
(C-D) Distributions of divergence values of all 955 dsRNA-response genes and different functional subsets of this group (see Methods for
details on each of the functional subsets): (C) Division by gene’s molecular function; (D) Division by biological process. FDR-corrected
empirical p-values are shown above each group; group size is shown inside each box.
Values of response divergence are estimated as !"# $%&', where (	and * are the coefficients for selection and drift (respectively) from a
fitted Ornstein-Uhlenbeck model (see Methods). Higher values (in y-axis in B-D) indicate faster response divergence.
(For all panels: *p<0.05, **p<0.01,***p<0.001).
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Figure 3: Cell-to-cell variability in the dsRNA response
(A) A comparison of divergence in response (measured in bulk transcriptomics across four species) and transcriptional variability in gene
expression between individual cells (measured in single-cell transcriptomics in human cells) in 955 dsRNA-response genes. In both measures, cells
were stimulated with dsRNA for 4 hour. Cell-to-cell variability was estimated using DM (higher values indicate higher levels of variability). Genes are
split into highly-, medium- and lowly-diverging genes based on their level of response divergence (x-axis, as described in Figure 1C). Cell-to-cell
variability values of highly-divergent genes were compared with lowly-divergent genes using Mann-Whitney test (*p<0.05, **p<0.01, ***p<0.001).
(B) Comparison of cell-to-cell variability of genes with and without a TATA-box (left) and CpG Islands (CGIs) (right); empirical p-values are shown.
Cell-to-cell variability values (y-axis) are taken from the DM estimations of human cells stimulated with dsRNA for 4 hours.
(C) A scatter plot showing divergence in response to dsRNA across species (x-axis) and transcriptional cell-to-cell variability in human cells
following 4 hours of dsRNA treatment (y-axis), of 955 dsRNA-response genes. Genes from three functional groups - cytokines, transcription factors
and kinases - are coloured, and some cytokines’ names are shown. The distributions of divergence values of each of the three functional groups
are shown above the scatter plot (with colours matching the scatter plot). The distributions of cell-to-cell variability values of these groups are shown
to the right.
(D) Violin plots showing the distribution of cell-to-cell variability values of cytokines, transcription factors and kinases following dsRNA treatment for
2,4 and 8 hours (gene groups are colours as in C).
(E) A network showing 14 genes that correlate in expression across cells with the chemokine CXCL10, in at least two species, following dsRNA
treatment. Here we include genes correlating with CXCL10 that are either cytokines (colored in purple) or genes that are known to be associated
with cytokine upregulation (genes with GO terms: “positive regulation of innate immune response” or “type I interferon signalling pathway”). See
Figure S14 for the network that includes all genes that were found to correlate in expression with CXCL10 in at least two species (colours of edges,
from light to dark grey, reflect the number of species in which this pair of genes was found to be correlated).
***
−1
0
1
2
CGI CGI−less
Ce
ll−
to
−c
ell
 va
ria
bil
ity
 (D
M
)***
−1
0
1
2
TATA TATA−less
Ce
ll−
to
−c
ell
 va
ria
bil
ity
 (D
M
)
A B
C D E
***
0
1
Low Medium High
Response divergence
Ce
ll−
to
−c
ell
 V
ar
iab
ilit
y (
DM
)
0
1
2
dsRNA 2h dsRNA 4h dsRNA 8h
Time course
Ce
ll−
to
−c
ell
 va
ra
ibi
lity
 (D
M
)
All rights reserved. No reuse allowed without permission. 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/137992doi: bioRxiv preprint first posted online May. 15, 2017; 
*** *
−10.0
−7.5
−5.0
−2.5
0.0
2.5
No Viral
Interactions
Viral
Interactors
Immunomodulators
Interactors
Re
sp
on
se
 d
ive
rg
en
ce
***
0
1
2
3
4
Low Medium High
Response divergence
log
10
[P
ro
te
in−
Pr
ot
ein
 In
te
ra
cti
on
s]
i i
 i
log
10
[P
ro
te
in−
Pr
ot
ein
 In
te
ra
cti
on
s]
***
0
1
2
3
4
Low Medium High
Response divergence
Ra
te
 o
f g
en
e 
ga
in 
an
d 
los
s (
−l
og
P)
***
0
5
10
15
Low Medium High
Response divergence
Ge
ne
 a
ge
***
0.0
0.2
0.4
0.6
0.8
Low Medium High
Response divergence
Se
qu
en
ce
 e
vo
lut
ion
 (d
N/
dS
)
Figure 4: Correspondence of response divergence and other evolutionary modes 
Comparing transcriptional divergence in response to dsRNA with other evolutionary mechanisms: In A-D 955 dsRNA-response genes are divided
by level of response divergence into three groups: highly divergent genes (top 25% most diverging genes, in pink), lowly divergent genes (25%
least diverging genes, in blue), and medium divergent genes (in purple) (as in Fig 1C). In each panel a different measure is shown in the y-axis for
each of the three groups (e.g. – coding sequence divergence in panel A). A a statistical comparison (Mann-Whitney test) is made between the
distribution of the tested measure’s values in highly and lowly divergent genes. (*p<0.05, **p<0.01, ***p<0.001.)
(A) Coding sequence divergence, as measured using dN/dS values across a clade of 29 mammals. Higher dN/dS values denote faster coding
sequence evolution.
(B) Rate at which genes are gained and lost within the gene family across the vertebrate clade (plotted as –logP). Higher values denote faster gene
gain and loss rate.
(C) Evolutionary age (estimated with Panther7 phylogeny and Wagner reconstruction algorithm). Values denote the branch number with respect to
human (distance from human in the phylogenetic tree), higher values indicate older age.
(D) Number of known physical interactions with other cellular proteins.
(E) Distribution of transcriptional response divergence values among dsRNA-response genes that do not interact with viruses (left), that interact
with at least one virus (middle), and that interact with viral immunomodulators (viral proteins that target the host immune system) (right). Empirical
p-values are shown.
(F) A scaled heatmap showing: (1) values of response divergence (computed as in Fig 1C), (2) cell-to-cell variability (as in Fig 2A), (3) coding
sequence divergence (dN/dS values, as in 3A), (4) gene age (as in 3C – younger genes have darker colours), (5) number of cellular interactions (as
in 3D) and (6) number of host-virus interactions (as in 3E), for example genes from three functional groups: (I) cytokines, chemokines and their
receptors, (II) transcription factors, (III) kinases and phosphates. Values are shown in a normalized scale between 0-100, so that in each column
the gene with the highest value is given a score of 100 and the gene with the lowest value is given a score of 0. Genes that have missing values
are coloured in grey.
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Materials	and	Methods:	
	
Ethics:	
This	project	has	been	approved	by	the	Wellcome	Trust	Sanger	Institute	Animal	
Welfare	and	Ethical	Review	Body	(AWERB).	Human	samples	have	been	obtained	580 
from	 open-access	 lines	 from	 the	 Human	 Induced	 Pluripotent	 Stem	 Cells	
Initiative	 (HipSci)1.	 Non-human	 primate	 skin	 samples	 were	 obtained	 from	
animals	assigned	to	unrelated	non-infectious	studies,	provided	by	Public	Health	
England’s	National	Infection	Service	(PHE)	in	accordance	with	Home	Office	(UK)	
guidelines	and	approved	by	the	Public	Health	England	Ethical	Review	Committee	585 
under	an	appropriate	UK	Home	Office	project	 license;	and	by	 the	Biomedical	
Primate	 Research	 Centre	 in	 the	 Netherlands	 (BPRC)	 in	 accordance	 with	 the	
Dutch	Law	on	Animal	Experimentation,	 following	EC	Directive	2010/63/EU	on	
the	protection	of	animals	used	for	scientific	purposes.	
Data	access	590 
Our	 results	 can	 be	 visualized	 in	 an	 online	 webserver	 -	
https://teichlab.sanger.ac.uk/ImmunityEvolution	 	 -	 where	 users	 can	 visualize	
histone	marks	across	species	and	individuals,	fold	changes	in	response	to	dsRNA	
and	 IFNB	 across	 species	 	 from	 	 bulk	 transcriptomics,	 as	 well	 as	 the	 gene	
expression	values	in	individual	cells	across	species	and	stimulation	time	course.		595 
Sequencing	 data	 is	 deposited	 in	 ArrayExpress	 and	 would	 become	
available	upon	publication.	
	
	
Experimental	methods:	600 
	
Tissue	culture	
	
We	cultured	primary	dermal	fibroblasts	from	low	passage	cells	(below	10)	that	
originated	 from	 sexually	mature	 females	 from	 four	 different	 species	 (human	605 
(European	ancestry),	rhesus	macaque,	black	6	mouse	and	brown	Norway	rat).	
All	skin	samples	originated	from	shoulders	and	were	extracted	and	grown	in	a	
similar	manner.	Stimulation	experiments	and	library	preparations	were	done	in	
identical	conditions	across	all	species	and	for	all	genomics	techniques.		For	each	
species	and	for	each	genomics	technique	we	used	several	biological	replicates.	610 
Details	on	the	numbers	of	individuals	used	in	each	technique	are	detailed	in	each	
technique’s	section	and	in	Table	S1.	
All rights reserved. No reuse allowed without permission. 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/137992doi: bioRxiv preprint first posted online May. 15, 2017; 
 
18	
Human	 cells	 were	 obtained	 from	 the	 Hipsci	 project	
(http://www.hipsci.org/	1).	Non-human	primate	cells	were	extracted	from	skin	
tissues	 that	 were	 incubated	 for	 2hrs	 with	 0.5%	 collagenase-A	 (Roche;	615 
11088815001)	after	mechanical	processing,	and	 then	 filtered	 through	100µm	
strainers	before	being	plated	and	passaged	prior	to	cryo-banking.	Rodent	cells	
were	 obtained	 from	 Cellbiologics	 where	 they	 were	 extracted	 using	 a	 similar	
enzymatic	extraction	protocol	using	skin	tissues	from	the	same	regions	of	the	
body	used	in	primates.			620 
	 Prior	 to	 stimulation,	 cells	 were	 thawed	 and	 grown	 for	 3	 days	 in	 ATCC	
fibroblast	growth	medium	(Fibroblast	Basal	Medium	(ATCC,	ATCC-PCS-201-030)	
with	Fibroblast	Growth	Kit-Low	serum	(ATCC,	PCS-201-041)	(supplemented	with	
Primocin	 (Invivogen,	 ant-pm-1)	 and	 Pen/Strep	 (Life	 Technologies,	 Cat.	 Code:	
15140122))–	 a	 controlled	medium	 that	 has	 proven	 to	 provide	 good	 growing	625 
conditions	for	fibroblasts	from	all	species,	having	slightly	less	than	24h	doubling	
times.	~18hrs	before	stimulation,	cells	were	trypsinized,	counted	and	100,000	
cells	 were	 seeded	 into	 6-well	 plates,	 leading	 to	 ~60-70%	 confluence	 in	 the	
beginning	of	the	stimulation	experiment.	Cells	were	stimulated	with	either:	(1)	
1ug/mL	 High-Molecular	 Weight	 poly	 I:C	 (Invivogen,	 Cat.	 Code:	 tlrl-pic)	630 
transfected	 with	 2uL/mL	 Lipofectamin	 2,000	 (ThermoFisher,	 Cat	 Number	
11668027)	 (these	 conditions	 lead	 to	 ~100%	 transfection	 efficiency	 across	
species	 within	 2	 hours	 post-transfection);	 (2)	 mock	 transfected	 with	
Lipofectamin	2,000;	 (3)	 stimulated	with	1,000	 IU	of	 IFNB	 for	8	hours	 (human	
IFNB	-	11410-2	(for	human	and	macaque	cells);	rat	IFNB	-	13400-1;	mouse	IFNB	635 
–	12401-1;	 all	 IFNs	were	obtained	 from	PBL,	 and	had	activity	 units	 based	on	
similar	virological	assays);	or	(4)	left	untreated.		
Additional	samples	in	human	and	mouse	were	stimulated	with	1,000	IU	
of	Cross-mammalian	IFN	(CMI,	or	Universal	Type	I	IFN	Alpha,	PBL,	Cat	Number	
11200-1).	 The	 latter	 stimulation	 was	 done	 to	 assess	 the	 effects	 of	 species-640 
specific	and	batch-specific	IFNB:	Using	cross-mammalian	IFN	allows	stimulating	
cells	from	different	species	with	the	same	IFN,	thus	allowing	to	infer	the	species-
specific	response	to	IFN.		The	concentrations	and	time	points	used	were	chosen	
following	 24-hour	 time-course	 calibration	 experiments	 and	 after	 testing	
different	concentrations.		645 
	 Human	 fibroblasts	 were	 also	 cultured	 in	 an	 alternative	 experimental	
condition	to	generate	a	larger	dataset	of	single	cells	and	enable	confirmation	of	
results	 across	 experimental	 settings	 (this	 batch	 is	 referred	 to	 as	 the	 third	
replicated	in	the	single-cell	analysis).	For	this,	cells	were	grown	in	DMEM,	high	
glucose,	GlutaMAX	Supplement,	pyruvate	(Life	Technologies,	Cat	code:	10569-650 
010),	 10%	Fetal	 Bovine	 Serum	 (Lab	 Tech,	 Cat	 code:	 FB-1001)	 and	Penicillin	 –	
Streptomycin	(Life	Technologies,	Cat	code:	15140122).	Cells	were	stimulated	for	
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2	and	6	hours	with	0.5ug/mL	High-Molecular	Weight	poly	 I:C	 (Invivogen,	Cat.	
Code:	tlrl-pic)	transfected	with	1uL/mL	Lipofectamin	2,000	(ThermoFisher,	Cat	
Number	11668027);	or	left	untreated,	before	trypsinization	and	processing.	655 
	
	
Bulk	RNA	sequencing		
	
Library	preparation	and	sequencing	660 
	
For	bulk	transcriptomics	analysis,	individuals	from	different	species	were	grown	
in	parallel	and	stimulated	with	dsRNA,	IFNB	(and	cross-mammalian	IFN)	and	with	
their	respective	controls.	In	total,	samples	from	6	humans,	6	macaques,	3	mice	
and	3	rats	were	used	(we	used	3	samples	for	rodents	due	to	their	lower	genetic	665 
variability).		Total	RNA	was	extracted	using	the	RNeasy	Plus	Mini	kit(Qiagen,	Cat	
Number	 	 74136),	 using	 QIAcube	 (Qiagen).	 RNA	 was	 then	 measured	 using	 a	
Bioanalyzer	2100	(Agilent	Technologies),	and	samples	with	RIN<9	were	excluded	
from	further	analysis.	
Libraries	were	 produced	 using	 the	 Kapa	 Stranded	mRNA-seq	 Kit	 (Kapa	670 
Biosystems,	 Kit	 code:	 KK8421).	 The	 Kapa	 library	 construction	 protocol	 was	
modified	 for	 automated	 library	 preparation	 by	 Bravo	 (Agilent	 Technologies).	
cDNA	 was	 amplified	 in	 13	 PCR	 cycles,	 and	 purified	 by	 Ampure	 XP	 beads	
(Beckman	 Coulter,	 Cat	 Number	 A63882)	 (1.8x	 volume)	 using	 Zephyr	 (Perkin	
Elmer).	 Prior	 to	 sequencing,	 libraries	were	quantified	using	MiSeq	 (25bp	PE).	675 
This	data	was	used	 for	pooling	 libraries	 in	equimolar	amounts	by	Coulter	NX	
(Span-8,	Beckman).	Pooled	samples	were	sequenced	on	an	Illumina	HiSeq	2500	
instrument,	using	paired-end	125-bp	reads.		
	
	680 
ChIP	sequencing		
	
Library	preparation	and	sequencing	
	
Samples	from	three	individuals	from	each	of	the	four	species	were	grown	and	685 
stimulated	 (with	poly	 I:C	or	 left	 untreated,	 as	described	above)	 in	parallel	 to	
samples	 collected	 for	 bulk	 RNA-seq.	 Following	 stimulation,	 sample	 were	
crosslinked	 in	 1%	 HCHO	 (prepared	 in	 1X	 DPBS)	 at	 room	 temperature	 for	 10	
minutes,	 and	 HCHO	 was	 quenched	 by	 the	 addition	 of	 glycine	 at	 a	 final	
concentration	of	0.125M.	Cells	were	pelleted	at	4°C	at	2000	x	g,	washed	with	690 
ice-cold	1X	DPBS	twice,	and	snapped	frozen	in	liquid	nitrogen.	The	cell	pellets	
were	stored	in	-80°C	until	further	stages	were	performed.	ChIPmentation	was	
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performed	 according	 to	 version	 1.0	 of	 the	 published	 protocol	 2	 with	 some	
modifications	at	the	ChIP	stage:	
Cell	pellets	were	lysed	in	300ul	ChIP	Lysis	Buffer	I	(50mM	HEPES.KOH,	pH	695 
7.5,	140mM	NaCl,	1mM	EDTA,	pH	8.0,	10%	Glycerol,	0.25%	NP-40,	0.5%	Triton	
X-100)	on	ice	for	10	minutes.	Cells	were	then	pelleted	at	4°C	at	2000	x	g	for	5	
minutes,	and	washed	by	300ul	ChIP	Lysis	Buffer	II	(10	mM	Tris.Cl,	pH	8.0,	200	
mM	NaCl,	1mM	EDTA,	pH	8.0,	0.5mM	EGTA,	pH	8.0),	and	pelleted	again	at	4°C	
at	2000	x	g	for	5	minutes.	Nuclei	were	resuspended	in	300ul	ChIP	Lysis	Buffer	III	700 
(10mM	Tris.Cl,	pH	8.0,	100mM	NaCl,	1mM	EDTA,	0.5mM	EGTA,	0.1%	Sodium	
Deoxycholate,	 0.5%	 N-Lauryolsarcosine).	 Chromatin	 was	 sonicated	 using	
Bioruptor	Pico	(Diagenode)	with	10	cycles	of	30	seconds	ON/30	seconds	OFF.	
30ul	10%	Triton	X-100	were	added	into	each	sonicated	chromatin,	and	insoluble	
chromatin	was	pelleted	at	16,100	x	g	at	4°C	for	10	minutes.	1ul	supernatant	was	705 
taken	as	an	input	control.	The	rest	of	the	supernatant	was	incubated	with	10ul	
Protein	 A	 Dynabeads	 (Invitrogen)	 pre-bound	 with	 1ug	 anti-H3K4me3	
(Diagenode	 Cat	 Number	 C15410003)	 or	 1ug	 anti-H3K27ac	 (Diagenode,	 Cat	
Number	 C15410196)	 in	 a	 rotating	 platform	 in	 a	 cold	 room	 overnight.	 Each	
immunoprecipitation	 (IP)	 was	 washed	 with	 500ul	 RIPA	 Buffer	 (50mM	710 
HEPES.KOH,	 pH	 7.5,	 500mM	 LiCl,	 1mM	 EDTA,	 1%	 NP-40,	 0.7%	 Sodium	
Deoxycholate,	check	components)	for	3	times.	Each	IP	was	then	washed	with	
500ul	10mM	Tris,	pH	8.0	twice,	and	resuspended	in	30ul	tagmentation	reaction	
mix	 (10mM	Tris.Cl,	 pH	8.0,	 5mM	Mg2Cl,	 1ul	 Tn5	 transposase	 (Nextera)).	 The	
tagmentation	reaction	was	put	on	a	thermomixer	at	37°C	for	10	minutes	at	800	715 
rpm	 shaking.	 Following	 tagmentation,	 each	 IP	was	washed	 sequentially	with	
500ul	RIPA	Buffer	twice,	and	1X	TE	NaCl	(10mM	Tris.Cl,	pH	8.0,	1mM	EDTA,	pH	
8.0,	 50mM	 NaCl)	 once.	 Elution	 and	 reverse-crosslinking	 were	 done	 by	
resuspending	the	beads	with	100ul	ChIP	Elution	Buffer	(50mM	Tris.Cl,	pH	8.0,	
10mM	EDTA,	pH	8.0,	1%	SDS)	on	a	thermomixer	at	65°C	overnight,	1,400	rpm.	720 
DNA	was	purified	by	MinElute	PCR	Purification	Kit	(QIAGEN,	Cat	Number	28004)	
and	 eluted	 in	 12.5ul	 Buffer	 EB	 (QIAGEN,	 Cat	 Number	 28004),	 which	 yielded	
~10ul	ChIPed	DNA.	
The	library	preparation	reactions	contained	the	following	reagents:	10ul	
purified	DNA	(from	the	above	procedure),	2.5ul	PCR	Primer	Cocktails	(Nextera	725 
kit,	Illumina,	Cat	Number	FC-121-1030),	2.5ul	N5xx	(Nextera	index	kit,	Illumina	
Cat	Number	FC-121-1012),	2.5ul	N7xx	(Nextera	index	kit	,	Illumina,	Cat	Number	
FC-121-1012),	7.5ul	NPM	PCR	Master	Mix	(Nextera	kit,	Illumina,	Cat	Number	FC-
121-1030)	The	PCR	cycles	were	as	follows:	72°C,	5	mins;	98°C,	2	mins;	98°C,	10	
secs,	63°C,	30	secs,	72°C,	20	secs]	X	12;	10°C	hold.	730 
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The	 amplified	 libraries	 were	 purified	 by	 double	 AmpureXP	 beads	
purification:	first	with	0.5X	bead	ratio,	keep	supernatant,	second	with	1.4X	bead	
ratio,	keep	bound	DNA.	Elution	was	done	in	20ul	Buffer	EB	(QIAGEN).	
1ul	of	library	was	run	on	an	Bioanalyzer	(Agilent	Technologies)	to	verify	
normal	size	distribution.	Pooled	samples	were	sequenced	on	an	Illumina	HiSeq	735 
2000	instrument,	using	paired-end	75-bp		
	
	
Single-Cell	RNA	sequencing	
	740 
Flow	cytometry	
	
For	 scRNA-seq,	 we	 performed	 two	 different	 biological	 replicates,	 with	 each	
replicate	having	one	 individual	 from	each	of	 the	 four	 studied	species.	A	 time	
course	of	dsRNA	stimulation	of	0,2,4,	and	8hrs	was	used	in	one	replicate,	and	a	745 
smaller	replicate	included	0,4,8hrs.	All	cells	from	the	same	biological	replicate	
were	sorted	in	identical	conditions	and	into	identical	plates.	Poly	I:C	transfection	
was	done	as	described	above.	 In	 the	 case	of	 sorting	with	 IFNLUX,	we	used	a	
rhodamine-labelled	poly	I:C,	to	collect	index	data	on	poly	I:C	transfection.	
Cells	were	sorted	with	either	Becton	Dickinson	INFLUX	(first	replicate)	or	750 
Beckman	Coulter	MoFlo	XDP	(second	replicate)	into	wells	containing	2uL	of	Lysis	
Buffer	(1:20	solution	of	RNase	Inhibitor	(Clontech,	Cat	Number	2313A)	in	0.2%	
v/v	 Triton	 X-100	 (Sigma-Aldrich,	 Cat	 Number	 T9284),	 spun	 down	 and	
immediately	 frozen	 at	 -80°.	 Technical	 positive	 and	negative	 controls	 of	 small	
bulk	with	 10	 cells	 or	with	 empty	wells	 respectively,	were	 used	 to	 assess	 the	755 
quality	 of	 the	processed	 cells.	 Cells	 from	different	 conditions	 (time	points	 or	
species)	were	sorted	based	on	a	Latin	square	design	to	minimize	biases	due	to	
specific	 locations	on	the	plate.	These	plates	were	 later	processed	together	to	
minimize	batch	effects.		
When	sorting	with	MoFlo	(smaller	biological	replicate),	a	pressure	of	15psi	760 
was	used	with	a	150µm	nozzle,	using	the	‘Single’	sort	purity	mode.	Dead	or	late-
apoptosis	 cells	 were	 excluded	 using	 Propidium	 Iodide	 at	 1µg/ml	 (Sigma,	 Cat	
Number	P4170)	and	single	cells	were	selected	using	FSC	W	vs	FSC	H.			
When	sorting	with	INFLUX	(larger	biological	replicate),	a	pressure	of	3psi	
was	used	with	 a	 200µm	nozzle,	with	 the	 “single”	 sort	mode.	 Index	data	was	765 
collected	 and	 the	median	 fluorescence	 intensity	 (MFI)	 of	 rhodamine-labelled	
poly	I:C	(InvivoGen,	tlrl-picr),	DAPI,	forward	and	side	scatter	was	retained.	Dead	
or	 late-apoptosis	 cells	were	excluded	using	100ng/ml	DAPI	 (4',6-diamidino-2-
phenylindole)	(Sigma,	Cat	Number	D9542).	DAPI	was	detected	using	the	355nm	
laser	(50mW)	using	a	460/50nm	bandpass	filter.		Rhodamine	was	detected	using	770 
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the	561nm	laser	(50mW),	using	a	585/29nm	bandpass	filter.	Single	cells	were	
collected	using	the	FSC	W	vs	FSC	H.	
	 In	addition	to	the	two	described	replicates	that	included	cells	from	all	four	
species,	human	cells	 from	3	 individuals	were	sorted	 in	a	 third	experiment	 (in	
parallel	to	cells	from	the	same	individuals	and	conditions	being	processed	using	775 
microfluidic	droplet	cell	capture).	Cells	were	sorted	with	 INFLUX	as	described	
above.		
	
Library	preparation	from	full-length	RNA	from	single	cells	and	sequencing	
	780 
Sorted	plates	were	processed	according	to	the	Smart-seq2	protocol3:	Oligo-dT	
primer	 (IDT),	 dNTPs	 (ThermoFisher,	 Cat	 Number	 10319879)	 and	 ERCC	 RNA	
Spike-In	Mix	(1:25,000,000	final	dilution,	Ambion,	Cat	Number	4456740)	were	
added	to	each	well,	and	Reverse	Transcription	(using	50U	SmartScribe,	Clontech	
Cat	Number	639538)	and	PCR	were	performed	following	the	original	protocol	785 
with	25	PCR	cycles.	cDNA	libraries	were	prepared	using	Nextera	XT	DNA	Sample	
Preparation	Kit	(Illumina,	Cat	Number	FC-131-1096),	according	to	the	protocol	
supplied	by	Fluidigm	(PN	100-5950	B1).	Quality	Checks	on	cDNA	were	done	using	
a	Bioanalyser	2100	(Agilent	Technologies).		Libraries	from	96	single	cells	were	
quantified	using	the	LightCycler	480	(Roche),	pooled	and	purified	using	AMPure	790 
XP	beads	(Beckman	Coulter)	with	Hamilton	384	head	robot	(Hamilton	Robotics).	
Pooled	samples	were	sequenced	on	an	Illumina	HiSeq	2500	instrument,	using	
paired-end	125-bp	reads.	
	
Library	preparation	from	single	cells	using	microfluidic	droplet	cell	capture	795 
	
Cells	from	three	human	individuals	were	grown,	stimulated	with	dsRNA	for	6hrs	
or	 left	 unstimulated,	 collected	 by	 trypsinization	 and	 processed	 in	 a	 10X	
Chromium	 machine	 (10X	 Genomics).	 Following	 multiplexing,	 libraries	 were	
prepared	 according	 to	 the	 manufacturer’s	 protocol.	 	 	 Pooled	 samples	 were	800 
sequenced	on	an	Illumina	HiSeq	2500	instrument,	using	paired-end	75-bp	reads.	
We	used	this	approach	as	a	second	experimental	technique	to	prepare	libraries	
from	single	cells,	to	confirm	our	results	regarding	cell-to-cell	variability,	obtained	
from	 the	 primary	method	 we	 use	 (Smart-seq2).	 This	 method	 is	 more	 highly	
parallel	in	cell	capture	but	less	sensitive	than	our	primary	plate-based	method	805 
(Smart-seq2)	as	a	single	cell	RNA-seq	technology4.	
	 	
	
Computational	methods:	
	810 
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Bulk	RNA	transcriptomics		
	
Read	mapping	to	annotated	transcriptome	
	
Adaptor	sequences	and	low-quality	score	bases	were	first	trimmed	using	Trim	815 
Galore	(version	0.4.1)	(with	the	parameters	“--paired	--quality	20	--length	20	-e	
0.1	 --adapter	 AGATCGGAAGAGC”).	 Trimmed	 reads	 were	 mapped	 and	 gene	
expression	 was	 quantified	 using	 Salmon	 (version	 0.6.0)	 5	 with	 the	 following	
command:	 "salmon	quant	 -i	 [index_file_directory]	 -l	 ISR	 	 -p	 8	 --biasCorrect	 --
sensitive	 --extraSensitive	 	 -o	 [output_directory]	 -1	 	 	 -g	820 
[ENSEMBL_transcript_to_gene_file]	 	 --useFSPD	 	 --numBootstraps	 100".	 Each	
sample	 was	 mapped	 to	 its	 respective	 species’	 annotated	 transcriptome	
(downloaded	 from	 ENSEMBL,	 version	 84:	 	 GRCh38	 for	 human,	MMUL_1	 for	
macaque,	GRCm38	for	mouse,	Rnor_6.0	 for	 rat).	We	only	 included	the	set	of	
coding	genes	(*.cdna.all.fa	files).	In	the	case	of	human,	we	removed	annotated	825 
secondary	 haplotypes	 of	 coding	 genes.	 	We	 did	 not	 include	 long	 non-coding	
RNAs	 since	 coding	 genes	 are	 the	 focus	 of	 this	 study	 and	 since	 current	
annotations	of	long	non-coding	RNAs	significantly	differ	in	numbers	and	quality	
between	species.		
	830 
Quantifying	differential	gene	expression	in	response	to	dsRNA	or	IFNB	
To	 quantify	 differential	 gene	 expression	 between	 treatment	 and	 control	 for	
each	species	and	for	each	treatment	separately,	we	used	edgeR	(version	3.12.1)6	
using	the	rounded	estimated	counts	returned	by	Salmon	in	the	previous	stage.		
This	was	done	only	for	genes	that	had	a	significant	level	of	expression	in	at	least	835 
one	of	the	four	species	(TPM>3	in	at	least	N-1	libraries,	where	N	is	the	number	
of	different	individuals	we	have	for	this	species	with	libraries	that	passed	quality	
control).	Significance	testing	was	done	using	the	exact	test	from	edgeR,	and	p-
values	were	corrected	using	FDR.	
	840 
	
Conservation	and	divergence	in	response		
	
Fold	change-based	phylogeny	
	845 
We	compared	the	overall	change	in	response	to	treatment	(dsRNA	and	to	IFNB)	
between	pair	 of	 species,	 by	 computing	 the	 Spearman	 correlation	 of	 the	 fold	
change	 in	 response	 treatment	 across	 all	 one-to-one	 orthologs	 that	 were	
expressed	in	at	least	one	species	(Figs	S1A-H).	Fold	change	was	calculated	with	
edgeR,	as	explained	above.			850 
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We	constructed	a	 tree	based	on	gene’s	changes	 in	expression	 in	 response	 to	
dsRNA	and	to	IFNB	using	9,835	expressed	genes	that	had	one-to-one	orthologs	
across	all	four	species	and	were	expressed	in	at	least	one	species	in	at	least	one	
condition	(Fig	S1I).	We	used	hierarchical	clustering,	using	the	command	hclust	
from	 the	 stats	R	package	 (version	3.3.2),	with	 the	distance	between	 samples	855 
computed	as	1-!,	where	!	is	the	pairwise	Spearman	correlation	between	each	
pair	of	species	mentioned	above	(and	thus,	a	greater	similarity,	reflected	in	a	
higher	correlation,	results	in	a	smaller	distance)	and	“average”	as	the	clustering	
method.	We	note	that	when	repeating	this	procedure	with	gene’s	p-values	we	
obtained	a	similar	phylogeny.		860 
	
Quantifying	gene	expression	divergence	using	Orenstein-Uhlenbeck	models	
	
The	Ornstein-Uhlenbeck	(OU)	process	was	suggested	as	an	appropriate	model	
to	study	the	evolution	of	gene	expression7	and	was	previously	used	to	model	865 
the	 evolution	 of	 gene	 expression	 in	 various	 systems,	 such	 as	 in	 mammalian	
tissues8	and	in	fly	embryonic	development9.		
OU	models	incorporate	selection	and	drift,	and	accordingly	include	two	
terms	 reflecting	 stochastic	and	deterministic	 forces.	The	model	describes	 the	
change	 of	 a	 quantitative	 character	 "	 over	 a	 small	 increment	 of	 time	 #	 as:	870 $" # = 	' ( − " # $# + 	+$,(#),	 where	 the	 first	 term	 describes	 the	
deterministic	force	of	selection,	and	the	second	term	is	the	stochastic	Brownian	
motion	 representing	 genetic	 drift.	 	 '	 is	 the	 strength	 of	 selection,	 +	is	 the	
strength	of	neutral	drift	and	(	is	the	trait’s	optimum.		
We	 used	 the	 ouch	 R	 package	 (version	 2.9-2)	 to	 fit	 OU	 and	 Brownian	875 
motion	models	to	our	data	of	fold	change	in	gene	expression	across	species.	We	
fitted	 8	 different	models	 to	 the	 species-specific	 fold	 change	 values	 for	 each	
expressed	gene.	We	used	a	phylogenetic	tree,	which	was	constructed	using	the	
concatenated	 nucleic	 acid	 sequences	 of	 all	 the	 expressed	 genes	 in	 each	
expression	program	(dsRNA	or	IFNB)	that	had	one-to-one	orthologs	across	the	880 
four	 species	 (MSA	 was	 created	 using	 MUSCLE,	 version	 3.710),	 and	 tree	 was	
reconstructed	using	PhyML,	version	3.011).	The	models	were	a	pure	Brownian	
motion	model,	reflecting	neutral	evolution,	and	7	Hansen	models	with	differing	
number	of	selective	optima.	Coefficients	values	for	selection	and	drift	('	and	+,	
respectively)	 were	 then	 retrieved	 from	 the	 model	 that	 best	 fitted	 the	 data,	885 
based	on	 the	Akaike	 Information	Criterion.	A	measure	of	 divergence	 in	 gene	
expression	 response	 was	 calculated	 from	 these	 values	 as:	 	 +/01 2345	 7.	 For	
simplicity,	 throughout	 the	manuscript	we	 refer	 to	 this	measure	as	 “response	
divergence”.	
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We	note	that	here	we	did	not	attempt	to	develop	an	extensive	model,	but	890 
rather	to	use	an	existing	model	that	captures	changes	 in	expression	between	
species	 while	 taking	 into	 account	 their	 known	 evolutionary	 relationships.	
Importantly,	when	we	 compare	 the	 divergence	 values	 obtained	with	 the	OU	
model	with	divergence	values	obtained	from	fitting	the	data	with	linear	models	
(see	below)	–	we	get	a	significant	agreement	between	the	two	approaches	(see	895 
Fig	S1A-F).		
	 For	 various	 analyses	 where	 we	 compare	 response	 divergence	 with	
another	 characteristics	 (e.g.	 –	 coding	 sequence	 evolution,	 active	 chromatin	
marks	divergence,	cell-to-cell	variability,	etc.),	 the	955	dsRNA-response	genes	
(genes	 that	 are	 differentially	 expressed	 in	 humans,	 with	 a	 corrected	 p-900 
value<0.01,	based	on	edgeR	exact	test)	were	split	into	three	groups,	based	on	
their	level	of	response	divergence	across	species:	(1)	highly	divergent	genes	(the	
top	25%	genes	with	the	highest	divergence	values),	 (2)	 lowly	divergent	genes	
(the	bottom	25%),	and	(3)	genes	with	medium	level	of	divergence	(the	middle	
50%).		905 
	
Quantifying	 gene	 expression	 divergence	 using	 linear	 models	 in	 bulk	
transcriptomics	and	in	single	cell	time	course	transcriptomics		
	
To	quantify	gene	expression	divergence	using	a	different	approach	to	the	above-910 
mentioned	OU	models,	we	fitted	a	linear	model	to	the	bulk	expression	data	of	
all	the	expressed	orthologous	genes	in	response	to	treatment	(dsRNA	or	IFNB)	
in	each	pair	of	species.	We	used	the	glmFit	command	in	the	edgeR	R	package	
(version	3.12.1),	to	fit	a	linear	equation	that	incorporates	species	and	treatment,	
as	follows:	6 = 	78 + 9: + ;8: : + =,	where	T	is	the	treatment	effect,	S	is	the	915 
species	effect,	T:S	is	the	interaction	between	treatment	and	species,	and	=	is	the	
residual	 error.	 	 We	 then	 extracted	 the	 fold-change	 and	 p-value	 for	 the	
interaction	 term	 (c),	 and	 used	 them	 as	 a	 proxy	 for	 divergence	 in	 expression	
between	species	 in	 response	 to	 treatment.	When	comparing	 the	 two	models	
(OU	and	linear	models),	we	observe	a	significant	agreement	between	the	two	920 
models	 (see	Fig	S3).	Thus,	 the	group	of	genes	 that	are	divergent	 in	 response	
across	species	is	robust	to	the	computational	approach	we	use	to	detect	them.	
	
Comparison	of	response	divergence	between	different	functional	groups		
	925 
To	compare	the	divergence	rates	between	sets	of	dsRNA-response	genes	that	
have	 different	 functions	 in	 the	 innate	 immune	 response,	 we	 split	 these	 955	
genes	 into	 the	 following	 functional	groups	 (all	 groups	are	mutually-exclusive,	
and	any	gene	that	belongs	to	two	groups	was	excluded	from	the	latter	group):		
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26	
We	first	grouped	genes	by	annotated	molecular	functions:	Viral	sensors	930 
(genes	that	belong	to	one	of	the	GO	categories:	GO:0003725	-	double-stranded	
RNA	binding,	GO:0009597	-	detection	of	virus;	GO:0038187	-	pattern	recognition	
receptor	 activity),	 Cytokine	 &	 chemokine	 receptors	 (GO:0004896	 -	 cytokine	
receptor	 activity;	 GO:0004950	 -	 chemokine	 receptor	 activity),	 Cytokines	 &	
chemokines	 (GO:0005125	 cytokine	 activity;	 GO:0008009	 chemokine	 activity),	935 
Transcription	 factors	 (taken	 from	 the	 Animal	 Transcription	 Factor	 DataBase	
(version	2.0)	12),	Chromatin	modulators	(GO:0016568	-	chromatin	modification,	
GO:0006338	 -	 chromatin	 remodelling,	 GO:0003682	 -	 chromatin	 binding,	
GO:0042393-	 histone	 binding),	 Kinases	 and	 phosphatases	 (GO:0004672	 -	
protein	 kinase	 activity;	 GO:0004721	 -	 phosphoprotein	 phosphatase	 activity),	940 
Ligases	 and	 deubiquitinases	 (GO:0016579	 protein	 deubiquitination;	
GO:0004842	-		ubiquitin-protein	transferase	activity	GO:0016874	ligase	activity),	
Other	 enzymes	 (mostly	 involved	 in	 metabolism	 rather	 than	 regulation	 -	
GO:0003824	 -	 catalytic	 activity).	 The	 divergence	 response	 values	 of	 these	
functional	 subsets	 were	 compared	 to	 the	 entire	 group	 of	 dsRNA-response	945 
genes.		
Next,	we	 grouped	 genes	 by	 biological	 processes	 that	 are	 known	 to	 be	
important	 in	 the	 innate	 immune	 response:	 	 Cellular	 defence	 (GO:0051607	 	 -	
defence	 response	 to	 virus),	 Inflammation	 (GO:0006954	 -	 inflammatory	
response),	 Apoptosis	 (GO:0006915	 -	 apoptotic	 process),	 and	 Regulation	 (the	950 
annotations	of	 regulation	that	are	specific	 to	 the	dsRNA-IFN	pathway	 include	
only	few	genes.	We	thus	merged	the	genes	that	are	annotated	as	transcription	
factors,	 chromatin	 modulators,	 kinases	 and	 phosphates	 or	 ligases	 and	
deubiquitinases,	since	all	these	group	include	numerous	genes	that	are	known	
to	regulate	the	innate	immune	response.)		955 
Gene	lists	belonging	to	the	mentioned	GO	annotations	were	downloaded	
using	QuickGo	13.	The	distribution	of	response	divergence	values	for	each	of	the	
functional	groups	was	compared	with	the	distribution	of	response	divergence	of	
the	entire	set	of	dsRNA-response	genes.	Plots	of	functional	groups	of	genes	in	
the	 dsRNA	 response	 are	 shown	 in	 Fig	 2	 (where	 genes	 are	 categorized	 by	960 
molecular	 functions	 (2C)	 or	 by	 biological	 process	 (2D)).	 Analogous	 plots	 for	
functional	 groups	 in	 the	 IFNB	 response	 (with	 841	 IFNB-response	 genes)	 are	
shown	in	Fig	S5.	
	
	965 
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27	
Conservation	of	active	chromatin	marks	analysis	
	
Alignment	and	peak	calling	of	ChIP-seq	reads	
	970 
ChIP-seq	reads	were	trimmed	using	trim_galore	(version	0.4.1)	with	“--paired	--
trim1	 --nextera”	 flags.	The	 trimmed	reads	were	aligned	 to	 the	corresponding	
reference	genome	(hg38	for	human,	rheMac2	for	macaque,	mm10	for	mouse,	
rn6	for	rat	–	all	these	genomes	correspond	to	the	transcriptomes	used	for	RNA-
seq	mapping)		from	the	UCSC	Genome	Browser	14	using	bowtie2	(version	2.2.3)	975 
with	default	settings	15.	 In	all	four	species	we	removed	the	Y	chromosome.	In	
the	case	of	human,	we	also	removed	all	alternative	haplotype	chromosomes.	
Following		alignment,	low-confident	mapping	and	improperly-paired	reads	were	
removed	by	samtools	16	with	“-q	30	–f	2”	flags.		
Enriched	 regions	 (peaks)	 were	 called	 using	 MACS2	 (v	 2.1.1)17	 with	 a	980 
corrected	p-value	cutoff	of	0.01	with	“-f	BAMPE	-q	0.01	-B	--SPMR”	flags,	using	
input	DNA	as	control.	The	genome	sizes	(the	argument	for	“-g”	flag)	used	were	
“hs”	for	human,	“mm”	for	mouse,	3.0e9	for	macaque	and	2.5e9	for	rat.	Peaks	
were	considered	reproducible	when	they	were	identified	in	at	least	two	of	the	
three	biological	replicates	and	overlapped	by	at	least	50%	of	their	length	(non-985 
reproducible	 peaks	 were	 excluded	 from	 subsequent	 analyses).	 Reproducible	
peaks	were	then	merged	to	create	consensus	peaks	from	overlapping	regions	of		
peaks	from	the	three	replicates,	by	using	mergeBed	from	the	bedtools	suite18.		
	
Gene	assignment	and	conservation	of	active	promoters	and	enhancers	990 
	
We	subsequently	linked	human	peaks	with	the	genes	they	might	be	regulating	
as	follows:	H3K4me3	consensus	peak	was	considered	the	promoter	region	of	a	
given	gene	if	its	centre	was	between	2kb	upstream	and	500bp	downstream	of	
the	annotated	TSS	of	the	most	abundantly-expressed	transcript	of	that	gene.	995 
Similarly,	H3K27ac	was	 considered	 the	enhancer	 region	of	 a	 given	gene	 if	 its	
centre	was	in	a	distance	above	1kb	and	below	1Mb,	and	there	was	no	overlap	
(of	1bp	or	more)	with	any	H3K4me3	peak.	
In	each	 case	where,	based	on	 the	distance	 criteria,	more	 than	a	 single	
peak	was	linked	to	a	gene	(or	more	than	a	single	gene	was	linked	to	a	peak),	we	1000 
took	only	the	closest	peak-gene	pair	(ensuring	that	each	peak	will	have	up	to	
one	gene	and	vice	versa).	
To	 compare	 active	 promoters	 and	 enhancers	 between	 species,	 we	
excluded	any	human	peak	that	could	not	be	uniquely	mapped	to	the	respective	
region	 in	 the	other	 species.	 This	was	done	by	 looking	 for	 syntenic	 regions	of	1005 
human	peaks	in	the	other	three	species	by	using	liftOver	19,	and	removing	peaks	
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28	
that	 have	either	 unmapped	 regions	or	more	 than	one	mapped	 region	 in	 the	
compared	species.	We	considered	syntenic	regions	with	at	least	10%	sequence	
similarity	 between	 the	 species	 (minMatch=0.1),	 with	 a	 minimal	 length	
(minSizeQ	 and	 minSizeT)	 corresponding	 to	 the	 length	 of	 the	 shortest	 peak	1010 
(128bp	in	H3K4	and	142bp	in	H3K27).		
We	defined	an	active	human	promoter	or	enhancer	as	conserved	if	a	peak	
was	 identified	 in	 the	corresponding	region	of	 the	other	species	 (we	repeated	
this	 analysis	 by	 comparing	 human	 with	 each	 of	 the	 other	 three	 species,	
separately).	 We	 compared	 the	 occurrence	 of	 conserved	 promoters	 and	1015 
enhancers	in	genes	that	are	highly	divergent	in	response	to	dsRNA	with	lowly	
divergent	genes,	and	used	Fisher	exact	test	to	determine	statistical	significance	
of	the	observed	differences	between	highly	and	lowly	divergent	genes.	Results	
are	shown	in	Figure	S4.	
	1020 
	
Promoter	sequence	analysis	
	
Promoter	sequence	evolution	analysis	
	1025 
PhyloP7	 values	 were	 used	 to	 assess	 promoter	 sequence	 conservation20.	
Sequence	 conservation	 quantification	 was	 done	 by	 taking	 the	 estimated	
nucleotide	substitution	rate	for	each	nucleotide	along	the	promoter	sequence	
(500bp	upstream	of	the	TSS).	When	several	annotated	transcripts	exist,	the	TSS	
of	the	most	abundantly	expressed	transcript	was	used.	 	The	substitution	rate	1030 
values	from	all	genes	were	aligned,	based	on	their	TSS	position,	and	a	mean	for	
each	of	the	500	positions	was	calculated	separately	for	the	group	of	genes	with	
high,	medium	and	low	response	divergence.	Two-sample	Kolmogorov-Smirnov	
test	was	used	to	compare	the	paired	distribution	of	rates	between	the	mean	of	
the	highly	divergent	and	the	mean	of	the	lowly	divergent	sets	of	genes.	To	plot	1035 
the	mean	values	of	the	three	sets	of	divergent	genes,	geom_smooth	function	
from	the	ggplot2	R	package	was	used	with	default	parameters	(with	loess	as	the	
smoothing	method)	(see	Fig	2A).		
	
Promoter	elements	analysis		1040 
	
Human	CpG	island	(CGI)	annotations	were	downloaded	from	the	UCSC	genome	
table	 browser	 (hg38),	 and	 CGI	 genes	 were	 defined	 as	 those	 with	 a	 CGI	
overlapping	their	core	promoter	(300bp	upstream	of	the	TSS	reference	position,	
and	100bp	downstream	of	it,	as	suggested	previously21).		Genes	were	defined	as	1045 
having	a	TATA	box	if	they	had	a	significant	match	to	the	Jaspar	TATA	box	matrix	
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29	
(MA0108.1)	in	the	100bp	upstream	of	their	TSS	by	FIMO22	with	default	settings	
(we	note	that	only	28	out	of	955	dsRNA-response	genes	had	a	matching	TATA-
box	motif	in	this	region).		
	 		1050 
	
Cell-to-cell	transcriptional	variability	analysis		
	
Read	mapping	and	quality	control	of	single-cell	RNA-SEQ	(full-length	RNA)	
	1055 
Gene	expression	was	quantified	in	a	similar	manner	to	the	description	of	bulk	
transcriptomics	 libraries,	with	the	addition	of	ERCCs	to	the	species’	reference	
transcriptomes.	Low-quality	cells	were	filtered	following	quality	control	criteria	
(cells	with	at	least	250,000	mapped	reads,	with	at	least	2,000	expressed	genes	
with	 TPM>3,	 with	 ERCC<10%	 and	MT<40%),	 resulting	 in	 728	 cells	 from	 one	1060 
biological	replicate	(with	a	dsRNA	stimulation	time	course	of	0,2,4,8	hours)	and	
240	cells	from	the	second	biological	replicate	(with	a	time	course	of	0,4,8	hours).	
A	 third	 replicate	 of	 human	 cells	 resulted	 in	 590	 high	 quality	 cells.	 Results	
throughout	the	manuscript	relate	to	the	larger	cross-species	biological	replicate,	
unless	otherwise	specified.		1065 
	
Quantifying	gene	expression	in	microfluidic	droplet	cell	capture	data	
	
Gene	expression	was	quantified	using	10X	Genomics’	Cell	Ranger	pipeline	for	
alignment,	 de-duplication	 and	 filtering	 (version	 1.2.0)	1070 
(https://support.10xgenomics.com/single-cell/software/pipelines/latest/what-
is-cell-ranger).		Low-quality	cells	were	removed,	so	that	only	cells	with	at	least	
1,000	expressed	genes	were	included,	resulting	in	a	total	of	4,468	high-quality	
cells.	
	1075 
Cell-to-cell	variability	analysis		
	
To	quantify	gene’s	biological	cell-to-cell	variability	we	have	applied	two	
different	and	complementary	computational	approaches:	
	1080 
	 (1)	DM	(Distance	to	Median)	 -	an	established	method,	which	calculates	
the	 cell-to-cell	 variability	 in	 gene	 expression,	 while	 accounting	 for	 the	
confounding	factors	of	gene	expression	level23.	This	is	done	by	first	filtering	out	
genes	 that	are	 lowly	expressed:	For	Smart-seq2	data	we	only	 included	genes	
that	have	an	average	expression	of	more	than	10	reads.	For	microfluidic	droplet	1085 
cell	capture	data,	we	used	genes	that	had	been	detected	with	a	UMI	of	at	least	
1	in	at	least	20	cells.	This	filtering	procedure	is	done	to	avoid	genes	that	display	
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30	
higher	levels	of	technical	variability	between	samples.		Secondly,	to	account	for	
gene	 expression	 level,	 the	 observed	 cell-to-cell	 variability	 of	 each	 gene	 is	
compared	with	its	expected	variability,	based	on	its	mean	expression	across	all	1090 
samples	and	in	comparison,	with	a	group	of	genes	with	similar	levels	of	mean	
expression.	 This	 distance	 from	 mean	 value	 (DM),	 is	 also	 corrected	 by	 gene	
length,	 yielding	 a	 value	 of	 variability	 that	 can	 be	 compared	 across	 genes	
regardless	of	their	length	and	mean	expression	values24.		
	 Results	 from	 DM	 analysis	 are	 shown	 in	 Figure	 3A-C	 (human	 cells,	1095 
stimulated	 with	 poly	 I:C	 for	 4	 hours),	 Figure	 4D	 (human	 cells,	 different	
stimulation	time	points),	Figure	S7	(all	four	species,	all	time	points),	and	Figure	
S8	 (human	 cells	 processed	 with	 microfluidic	 droplet	 capture).	 Analysis	 was	
repeated	with	the	second	cross-species	replicate	and	gave	similar	results	(data	
not	shown).			In	Figures	3D	and	S12	we	show	cell-to-cell	variability	values	in	a	1100 
comparative	manner	across	conditions.	Specifically	for	these	plots,	we	used	a	
set	 of	 genes	 that	 have	 at	 least	 5	 reads	 in	 each	 of	 the	 stimulated	 conditions	
(ensuring	a	comparable	set	of	expressed	genes	across	all	conditions).	We	used	
this	set	of	mutual	genes,	to	compute	DM	for	each	of	the	stimulated	time	points.	
	1105 
	 (2)	As	a	second	approach,	we	used	BASiCS25	–	a	method	that	is	based	on	
a	Bayesian	algorithm	developed	specifically	to	identify	truly	biological	variation	
in	gene	expression	in	single-cell	transcriptomics	data.	To	regress	out	variation	
that	 stems	 from	 technical	 well-to-well	 variation,	 it	 uses	 the	 variation	 in	
externally	spiked-in	RNA	molecules26	to	infer	what	is	the	likely	level	of	technical	1110 
noise,	based	on	each	gene’s	variation	and	overall	expression.		
	 We	used	BASiCS	with	defaults	parameters,	taking	into	account	genes	that	
were	expressed	in	at	least	two	cells	(with	TPM>1).	We	verified	that	the	model’s	
parameters	were	converging	prior	to	the	20,000	iterations	“burn	period”,	and	
ran	the	model	for	a	further	20,000	iterations	using	a	thinning	period	of	10.	For	1115 
each	gene,	the	parameter	representing	biological	variability	(>)	was	extracted.		
	 Results	from	BASiCS	analysis	are	shown	in	Figure	S9.		
	
Analysis	of	cell	states	in	the	innate	immune	response	
	1120 
To	look	at	cell	response	levels	in	depth,	we	used	the	third	replicate	of	human	
cells	(from	which	we	have	the	largest	numbers	of	cells	and	from	which	we	have	
processed	 cells	 from	 two	 different	 library	 preparation	 methods	 (10X	
microfluidic	droplet	capture	and	Smart-seq2).	
	 Previous	 studies	 using	 different	 systems	 have	 indicated	 that	 cells	1125 
responding	to	pathogen-associated	molecular	patterns	such	as	poly	I:C	or	LPS,	
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31	
often	display	different	levels	of	response,	where	some	cells	exhibit	a	higher	level	
of	response	than	other	responding	cells27,28.		
	 To	 study	 the	 effects	 of	 these	 response	 levels	 on	 gene	 cell-to-cell	
variability,	we	used	590	human	cells	that	were	stimulated	with	poly	I:C	for	2	or	1130 
6	hours,	or	left	unstimulated.		We	plotted	the	results	of	a	Principal	Component	
Analysis	 (PCA)	 on	 these	 cells,	 and	 observed	 that	 the	 first	 PC	 distinguishes	 a	
population	of	cells	 that	are	closer	 to	the	unstimulated	cells	 (lowly	responsive	
cells),	from	a	population	that	is	further	away	(highly	responsive	cells)	(Fig	S10A).	
As	expected,	the	later	stimulation	time	point	(6	hours)	has	a	higher	fraction	of	1135 
highly	responding	cells	than	the	earlier	time	point.		
	 These	 two	populations	display	different	 levels	of	 expression	of	 dsRNA-
upregulated	genes	(Fig	S10B).	We	define	dsRNA-upregulated	genes	as	the	set	of	
genes	 exclusively	 upregulated	 in	 the	 primary	 response,	 following	 dsRNA	
treatment	(having	a	corrected	p-value<0.01	in	edgeR	DE	analysis),	which	are	not	1140 
stimulated	by	IFNB	(having	p-values>0.3	in	edgeR	DE	analysis	of	IFNB.	These	two	
sets	of	responding	cells	also	differ	 in	the	fraction	of	cells	expressing	IFNB	(Fig	
S10C).	We	use	 these	 genes	 to	 define	 two	 clusters	 of	 cells	 (using	 hierarchical	
clustering,	 with	 ward.D2	 as	 the	 method,	 and	 with	 Euclidian	 distance)	 –	 see	
Figure	 S10D.	 The	 left	 cluster	 constitutes	 the	 “lowly	 responding	 cells”,	 which	1145 
cluster	 together	with	 the	unstimulated	 cells,	whereas	 the	 “highly	 responding	
cells”	appear	in	the	right	cluster.		
	 We	repeated	the	cell-to-cell	variability	analysis	using	the	DM	method	on	
each	population	(separately	for	each	of	the	two	populations	at	2	hours	and	at	6	
hours).	Using	these	DM	values,	we	plot	the	divergence	of	lowly-,	medium-	and	1150 
highly-divergent	genes	(as	in	Fig	3A),	separately	for	highly	and	lowly	responsive	
cells	in	Fig	S10E.	Similar	to	the	analysis	done	in	Main	Fig	3A	(where	we	did	not	
separate	cells	by	response	levels),	highly	diverging	genes	have	higher	cell-to-cell	
variability	in	each	cell	state	and	in	each	time	point.				
	1155 
Cytokine	co-expression	analysis	
	
For	 analysis	 of	 co-expression	 within	 the	 set	 of	 cytokines,	 we	 correlated	 the	
expression	of	these	genes	in	our	largest	dataset	-	1,922	human	cells	(Spearman	
correlation),	which	were	stimulated	with	dsRNA	for	6	hours	and	processed	using	1160 
microfluidic	droplet	cell	capture	(see	Fig	S14).		
	 For	 correlation	of	 cytokines	with	all	 genes	expressed	across	 stimulated	
cells	 and	 in	 each	 species,	 we	 calculated	 Spearman	 correlation	 of	 expression	
between	pairs	of	genes	in	dsRNA-stimulated	cells	(dsRNA-transfected	cells	for	
2,	4	and	8	hours)	for	each	of	the	four	species.	For	the	13	cytokines	that	were	1165 
found	 to	 cluster	 in	 the	 human	 data	 (Fig	 S14),	 we	 define	 a	 set	 of	 ‘cytokine-
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32	
correlated’	 genes	 -	 those	with	 a	 correlation	 of	! >0.3	 -	 as	 genes	 that	 highly	
correlate	 with	 cytokine	 expression	 in	 response	 to	 dsRNA.	 We	 ranked	 these	
genes	 (based	on	how	many	 cytokines	 each	 gene	was	 found	 to	be	 correlated	
with)	and	used	GOrilla29	to	find	enriched	GO	terms	(Table	S3A).	1170 
	 Using	 the	 13	 cytokines	 described	 above,	 we	 repeated	 co-expression	
analysis	 in	each	of	 the	other	3	species	 (macaque,	rat	and	mouse),	calculating	
correlation	 with	 all	 expressed	 genes.	 We	 then	 used	 the	 categorisation	 of	
‘cytokine-correlated’	from	human	data	(described	above)	to	split	genes	into	two	
categories:	those	which	correlate	with	cytokines	in	human,	and	those	which	are	1175 
‘non-correlated’.	 Using	 this	 grouping,	 we	 compared	 the	 correlation	 values	
between	the	‘cytokine-correlated’	and	‘non-correlated’	in	each	species	using	a	
Kolmogorov-Smirnov	test.	We	observe	that	the	‘cytokine-correlated’	genes	have	
higher	 correlation	 values	 in	 macaque,	 mouse	 and	 rat	 than	 ‘non-correlated’	
genes	(p=2.0x10-77	in	macaque,	p=3.1x10-36	in	rat,	p=3.0x10-25	in	mouse).	1180 
	 For	 the	 chemokine	 CXCL10,	 we	 built	 a	 network	 (using	 CytoScape30)	 of	
genes	 that	 correlate	with	CXCL10	 in	 dsRNA-stimulated	human	 cells	 and	 in	 at	
least	one	more	species.	The	full	network	consists	of	34	genes	and	is	shown	in	Fig	
S14.	A	subset	of	this	network	is	shown	in	Fig	3E,	where	we	only	include	cytokine	
and	chemokines	and	genes	known	to	be	involved	in	upregulation	of	cytokines	1185 
(having	the	GO	terms:	“positive	regulation	of	innate	immune	response”	or	“type	
I	interferon	signalling	pathway”).	
	
	
Analysis	of	different	evolutionary	modes	1190 
	
Coding	sequence	evolution	analysis	
	
The	 ratio	 dN/dS	 of	 non-synonymous	 to	 synonymous	 codon	 substitutions,	 of	
human	genes	across	the	mammalian	clade	was	obtained	from	a	previous	study	1195 
using	 orthologous	 genes	 from	 29	 mammals31.	 Distributions	 of	 dN/dS	 values	
were	computed	for	each	of	the	three	groups	of	genes	with	 low,	medium	and	
high	 divergence	 in	 response	 to	 dsRNA,	 and	 are	 plotted	 in	 Figs	 4A.	 The	
distributions	 of	 dN/dS	 values	 in	 lowly	 and	 highly	 divergent	 genes	 were	
compared	using	Mann-Whitney	test.	1200 
We	also	compared	response	divergence	with	dN/dS	values	estimated	in	
two	additional	 sources:	 (1)	 dN/dS	 values	 computed	based	on	24	mammalian	
genomes32,	 and	 (2)	 pairwise	 dN/dS	 values	 of	 human-mouse,	 human-rat	 and	
human-macaque	 taken	 from	ENSEMBL.	 	 In	all	 cases	when	using	 the	different	
dN/dS	 estimates,	 we	 observe	 the	 same	 trend,	 where	 genes	 that	 are	 highly	1205 
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33	
divergent	in	response	to	dsRNA	have	higher	dN/dS	values	in	comparison	with	
lowly	divergent	genes	(data	not	shown).		
		
Rate	of	gene	gain	and	loss	analysis	
	1210 
The	significance	at	which	gene’s	family	has	experienced	higher	rate	of	gene	gain	
and	loss	in	the	course	of	vertebrate	evolution,	in	comparison	with	other	gene	
families,	was	retrieved	from	ENSEMBL33.	The	statistics	provided	by	ENSEMBL	is	
calculated	based	on	the	CAFE	method34,	which	estimates	the	global	birth	and	
death	rate	of	gene	families	and	identifies	gene	families	that	have	accelerated	1215 
rates	 of	 gain	 and	 loss.	 Distributions	 of	 the	 p-values	 from	 this	 statistic	 were	
computed	 for	each	of	 the	 three	groups	of	genes	with	 low,	medium	and	high	
divergence	 in	 response	 to	 dsRNA	 and	 are	 plotted	 as	 the	 negative	 logarithm	
values	 in	 Fig	 4B.	 The	 distributions	 of	 lowly	 and	 highly	 diverging	 genes	 were	
compared	using	Mann-Whitney	test.	1220 
	
Gene	age	analysis	
	
Gene	age	estimations	were	obtained	from	ProteinHistorian35.	 	To	ensure	that	
the	 results	 are	not	biased	by	 a	particular	method	of	 ancestral	 protein	 family	1225 
reconstruction	or	by	specific	gene	family	assignments,	we	used	eleven	different	
estimates	for	mammalian	genes	(combining	five	different	databases	of	protein	
families	with	two	different	reconstruction	algorithms	for	age	estimation,	as	well	
as	 an	 estimate	 from	 the	 phylostratigraphic	 approach).	 For	 each	 gene,	 age	 is	
defined	with	respect	to	the	species	tree,	where	a	gene’s	age	corresponds	to	the	1230 
branch	in	which	its	family	is	estimated	to	have	appeared	(thus,	larger	numbers	
indicate	evolutionarily	older	genes).	
The	age	distributions	of	lowly	and	highly	diverging	genes	were	compared	
using	a	Mann-Whitney	test.	Data	for	gene	age	in	comparison	with	divergence	in	
response	to	dsRNA	is	shown	in	Fig	4C	(using	Panther7	phylogeny	and	Wagner	1235 
reconstruction	algorithm)	and	in	Fig	S16A	(for	all	11	combinations	of	gene	family	
assignments	and	ancestral	family	reconstructions).		
In	addition,	we	tested	whether	results	regarding	gene	age	estimation	are	
confounded	by	the	ability	to	detect	orthologs,	which	can	be	affected	by	the	rate	
in	which	a	gene’s	coding	sequence	has	diverged.	For	this,	plotted	in	Fig	S15B,	we	1240 
separated	 the	 955	 dsRNA-response	 genes	 based	 on	 their	 coding	 sequence	
divergence,	into	four	quartiles.	In	each	quartile,	we	plot	the	estimation	of	gene	
age	for	the	genes	that	are	highly-,	medium-,	or	lowly-diverging	in	response	to	
dsRNA.	Gene	age	estimations	are	shown	using	four	methods	of	gene	estimation.	
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In	each	case,	we	observe	that	the	trend	of	highly-divergent	genes	to	be	younger	1245 
than	lowly-divergent	genes	is	maintained.		
		
Cellular	protein-protein	interactions	analysis		
	
Data	on	number	of	experimentally-validated	protein-protein	interactions	(PPIs)	1250 
for	human	genes	was	obtained	from	STRING	(version	10)36.	Distributions	of	PPIs	
for	 genes	 with	 low,	medium	 and	 high	 divergence	 in	 response	 to	 dsRNA	 are	
plotted	 in	 Fig	 4D.	 The	distributions	of	 lowly	 and	highly	diverging	 genes	were	
compared	using	Mann-Whitney	test.	
	1255 
Host-virus	interactions	analysis		
	
Data	 on	 host-virus	 protein-protein	 interactions	 was	 downloaded	 from	 the	
VirusMentha	database37,	and	combined	with	two	additional	papers	that	have	
annotated	host-virus	protein-protein	interactions32,38.		We	split	the	955	dsRNA-1260 
response	genes	into	genes	with	known	viral	interactions	(genes	whose	protein	
products	were	reported	to	interact	with	at	least	one	viral	protein),	and	genes	
with	no	known	viral	interactions:	“Viral	Interactors”	and	“No	viral	Interactions”	
respectively,	 in	Figure	4E.	 In	addition,	we	define	a	subset	of	genes	within	the	
viral	 interactors	 set:	 those	 known	 to	 interact	 with	 viral	 proteins	 that	 are	1265 
immunomodulators	 (proteins	 known	 to	 target	 the	 host	 immune	 system	 and	
modulate	its	response,	obtained	from	Pichlmair,	A.	et	al.	39).	The	distributions	
for	each	set	were	compared	using	empirical	p-values.	
	
	1270 
Statistical	analysis		
	
Statistical	 analyses	 were	 done	 with	 R	 version	 3.3.2.	 Empirical	 p-values	 were	
calculated	in	cases	where	two	compared	groups	had	a	large	difference	in	their	
sizes,	by	randomly	subsampling	the	larger	group	to	the	size	of	the	smaller	group	1275 
10,000	times,	and	comparing	the	resulting	median	(or	mean)	of	each	of	these	
subsets	to	the	median	(or	mean)	of	the	compared	smaller	group.	Throughout	
the	paper,	***	denotes	p-value<0.001,	**	p-value<0.01,	*	p-value<0.05.		
	
	1280 
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